Versus Systems (VS) 20-F 29 Mar 23 2022 FY Annual report (foreign) Financial data

Document And Entity Information

Document And Entity Information	12 Months Ended
	Dec. 31, 2022 shares
Document Information Line Items
Entity Registrant Name	VERSUS SYSTEMS INC.
Trading Symbol	VS
Document Type	20-F
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding	4,172,171
Amendment Flag	false
Entity Central Index Key	0001701963
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-39885
Entity Incorporation, State or Country Code	A1
Entity Address, Address Line One	1558 West Hastings Street
Entity Address, City or Town	Vancouver
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V6G 3J4
Entity Address, Country	CA
Title of 12(b) Security	Common Shares
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Document Accounting Standard	International Financial Reporting Standards
Auditor Name	Ramirez Jimenez International CPAs
Auditor Location	Irvine, CA
Auditor Firm ID	820
Business Contact
Document Information Line Items
Entity Address, Address Line One	6701 Center Drive West
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90045
Contact Personnel Name	Matthew Pierce
Entity Address, Address Line Two	Suite 480
City Area Code	(310)
Local Phone Number	242-0228

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 1,178,846	$ 1,678,156	$ 2,283,262
Receivables, net of allowance (Note 5)	60,749	123,617	464,873
Deferred financing costs (Note 3)		174,813	398,276
Prepaids and other current assets	223,226	377,926	18,225
Total current assets	1,462,821	2,354,512	3,164,636
Restricted deposit (Note 6)	8,489	9,068	8,851
Deposits	100,000	100,000	98,393
Property and equipment, net (Note 7)	172,841	326,945	481,861
Goodwill (Note 9)		6,580,660
Intangible assets (Note 10)	7,058,366	9,172,507	1,737,416
Total Assets	8,802,517	18,543,692	5,491,157
Current liabilities
Accounts payable and accrued liabilities (Note 11, Note 12 and Note 14)	522,012	832,399	1,459,707
Deferred revenue	69,273	193,504
Notes payable - Related Party (Note 12)	2,604,713	2,107,668	2,290,798
Lease liability (Note 19)	128,560	239,323	209,137
Total current liabilities	3,324,558	3,372,894	3,959,642
Non-current liabilities
Lease liability (Note 19)		128,560	432,114
Warrant liability (Note 3)		361,055
Notes payable - Related Party (Note 12)		678,515	2,237,751
Total liabilities	3,324,558	4,541,024	6,629,507
Share capital (Note 13)
Common shares	122,353,525	110,226,715	82,046,672
Commitment to issue shares (Note 13)		2,703,326
Class “A” shares	28,247	28,247	28,247
Reserves (Note 13)	14,506,758	10,661,294	8,663,301
Cumulative translation adjustment	154,970		(86,609)
Deficit	(125,182,412)	(100,995,334)	(86,596,261)
Equity (Deficit) total	11,861,088	22,624,249	4,055,351
Non-controlling interest (Note 8)	(6,383,129)	(8,621,581)	(5,193,701)
Total Equity	5,477,959	14,002,668	(1,138,350)
Total Liabilities and Equity	$ 8,802,517	$ 18,543,692	$ 5,491,157

Consolidated Statements of Loss

Consolidated Statements of Loss and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
REVENUES
Revenues	$ 1,108,840	$ 768,650	$ 1,390,018
EXPENSES
Amortization (Note 7)	273,309	304,904	240,820
Amortization of intangible assets (Note 10)	2,937,423	2,009,714	1,272,435
Consulting fees (Note 3)	861,924	582,998	465,252
Foreign exchange (gain) loss	(45,985)	1,087,110	24,719
Impairment of goodwill and other intangibles (Note 9)	8,254,000
Office and miscellaneous expenses	1,011,693	557,606	255,863
Interest expense	122,992	153,425	234,087
Professional fees (Note 14)	1,041,293	2,711,916	780,534
Salaries and wages (Note 14)	5,923,782	5,202,213	2,564,830
Sales and marketing	144,057	879,683	486,249
Software delivery costs	1,079,387	615,117	257,924
Share-based compensation (Note 13)	1,567,583	2,145,928	1,049,135
Total operating loss	(22,062,618)	(15,481,964)	(6,241,830)
Finance expense (Note 12)	(60,770)	(225,196)	(276,602)
Change in fair value of warrant liability (Note 3)	361,055	(2,024,580)
Loss on disposal of marketable securities and notes payable		(116,152)	(378,718)
Other expense			(13,890)
Net loss	(21,762,333)	(17,847,892)	(6,911,040)
Other comprehensive loss:
Foreign currency translation (gain) loss	(154,970)		447,302
Loss and comprehensive loss	(21,607,363)	(17,847,892)	(7,358,342)
Total other comprehensive loss attributable to:
Shareholders	(154,970)		117,629
Non-controlling interest			329,673
Comprehensive income	(154,970)		447,302
Comprehensive loss attributable to:
Shareholders	(19,469,478)	(14,399,072)	(5,893,682)
Non-controlling interest	(2,137,885)	(3,448,820)	(1,464,660)
Comprehensive income net	$ (21,607,363)	$ (17,847,892)	$ (7,358,342)
Basic and diluted loss per common share attributable to Versus Systems Inc. (in Dollars per share)	$ (11.63)	$ (15.11)	$ (8.85)
Weighted average common shares outstanding (in Shares)	1,660,370	952,828	648,313

Consolidated Statements of Lo_2

Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements Of Loss And Comprehensive Loss Abstract
Diluted loss per common share attributable to Versus Systems Inc.	$ (11.63)	$ (15.11)	$ (8.85)

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity (Deficit) - USD ($)	Number of Common Shares	Number of Class “A” Shares	Common Shares	Commitment to issue shares	Class “A” Shares	Reserves	Share subscriptions received	Currency translation adjustment	Deficit	Equity	Non-controlling Interest	Total
Balance at Dec. 31, 2019			$ 74,639,357		$ 28,247	$ 7,409,092	$ 230,947	$ 31,020	$ (80,820,209)	$ 1,518,455	$ (3,729,041)	$ (2,210,586)
Balance (in Shares) at Dec. 31, 2019	563,702	338
Shares issued in private placement			2,870,313			42,164				2,912,477		2,912,477
Shares issued in private placement (in Shares)	63,169
Share subscriptions received			230,947				(230,947)
Contribution benefit						170,329				170,329		170,329
Exercise of warrants			3,542,474							3,542,474		3,542,474
Exercise of warrants (in Shares)	70,410
Shares issued for services and investment			753,583							753,583		753,583
Shares issued for services and investment (in Shares)	18,042
Exercise of options			9,999			(7,419)				2,580		2,580
Exercise of options (in Shares)	250
Stock-based compensation						1,049,135				1,049,135		1,049,135
Cumulative translation adjustment								(117,629)		(117,629)	(329,673)	(447,302)
Loss and comprehensive loss									(5,776,053)	(5,776,053)	(1,134,987)	(6,911,040)
Balance at Dec. 31, 2020			82,046,672		28,247	8,663,301		(86,609)	(86,596,261)	4,055,351	(5,193,701)	(1,138,350)
Balance (in Shares) at Dec. 31, 2020	715,573	338
Shares issued in public offering			11,040,000							11,040,000		11,040,000
Shares issued in public offering (in Shares)	98,134
Share issuance costs			(1,558,277)							(1,558,277)		(1,558,277)
Exercise of warrants			379,814			(22,905)				356,909		356,909
Exercise of warrants (in Shares)	6,417
Shares issued for warrant exercise			1,615,058							1,615,058		1,615,058
Shares issued for warrant exercise (in Shares)	14,357
Stock-based compensation						66,616				66,616		66,616
Cumulative translation adjustment								(93,521)		(93,521)	(262,106)	(355,627)
Loss and comprehensive loss									(9,573,290)	(9,573,290)	(995,875)	(10,569,165)
Change in accounting policy - presentation currency (Note 4)								180,130		180,130	283,046	463,176
Balance at Feb. 01, 2021			93,523,267		28,247	8,707,012			(96,169,552)	6,088,975	(6,168,636)	(79,660)
Balance (in Shares) at Feb. 01, 2021	834,481	338
Shares issued with acquisition			10,532,735							10,532,735		10,532,735
Shares issued with acquisition (in Shares)	103,377
Commitment to issue shares				2,703,326						2,703,326		2,703,326
Shares issued for services			206,614							206,614		206,614
Shares issued for services (in Shares)	1,954
Exercise of warrants			5,555,728			(108,960)				5,446,768		5,446,768
Exercise of warrants (in Shares)	89,269
Exercise of options			408,370			(16,071)				392,299		392,299
Exercise of options (in Shares)	7,870
Stock-based compensation						2,079,312				2,079,312		2,079,312
Loss and comprehensive loss									(4,825,782)	(4,825,782)	(2,452,945)	(7,278,726)
Balance at Dec. 31, 2021			110,226,715	2,703,326	28,247	10,661,294			(100,995,334)	22,624,249	(8,621,581)	14,002,668
Balance (in Shares) at Dec. 31, 2021	1,036,951	338
Shares issued in private placement			1,119,373							1,119,373		1,119,373
Shares issued in private placement (in Shares)	412,292
Shares issued with acquisition			425,445	(2,703,326)		2,277,881
Shares issued with acquisition (in Shares)	4,196
Shares issued in public offering			12,132,360							12,132,360		12,132,360
Shares issued in public offering (in Shares)	2,707,291
Share issuance costs			(1,736,662)							(1,736,662)		(1,736,662)
Holdco shares exchanged for common shares			186,294						(4,562,631)	(4,376,337)	4,376,337
Holdco shares exchanged for common shares (in Shares)	11,441
Stock-based compensation						1,567,583				1,567,583		1,567,583
Cumulative translation adjustment								154,970		154,970		154,970
Loss and comprehensive loss									(19,624,448)	(19,624,448)	(2,137,885)	(21,762,333)
Balance at Dec. 31, 2022			$ 122,353,525		$ 28,247	$ 14,506,758		$ 154,970	$ (125,182,412)	$ 11,861,088	$ (6,383,129)	$ 5,477,959
Balance (in Shares) at Dec. 31, 2022	4,172,171	338										338

Condensed Interim Consolidated

Condensed Interim Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES
Loss for the period	$ (21,762,333)	$ (17,847,892)	$ (6,911,040)
Items not affecting cash:
Amortization (Note 7)	273,309	335,697	258,757
Amortization of intangible assets (Note 10)	2,937,423	2,009,714	1,272,435
Impairment of goodwill and other intangibles	8,254,000
Shares issued for services		206,614	242,023
Finance expense	60,770	225,197	276,602
Loss on sale of investment			378,718
Accrued interest	20,861	39,836	62,076
Factoring fees			38,727
Effect of foreign exchange	72,947	516,877	(410,189)
Change in fair value of warrant liability	(361,055)	361,055
Forgiveness on government loan			(448,504)
Share-based compensation	1,567,583	2,145,928	1,049,135
Changes in non-cash working capital items:
Receivables	62,868	378,975	(430,693)
Prepaids and other assets	154,700	(183,391)	3,332
Deferred revenue	(124,231)	70,333
Accounts payable and accrued liabilities	(310,387)	(1,152,162)	381,854
Cash used in operating activities	(9,153,545)	(12,893,217)	(4,236,767)
FINANCING ACTIVITIES
Proceeds from notes payable			968,674
Proceeds from Government PPP loan			638,905
Repayment of notes payable – related party	(63,819)	(462,229)	(258,661)
Proceeds from warrant exercises		5,446,769
Proceeds from share issuances	13,251,733	11,040,000	6,465,288
Proceeds from option exercises		392,299
Payments for lease liabilities	(260,185)	(282,087)	(305,493)
Receivable factoring costs			(38,727)
Payments of share issuance costs	(1,736,662)	(1,334,814)	(81,424)
Cash provided by financing activities	11,191,067	14,799,938	7,388,562
INVESTING ACTIVITIES
Acquisition of a business		(85,101)
Purchase of equipment	(40,211)	(74,478)
Proceeds from sale of investments			141,928
Development of intangible assets	(2,496,621)	(2,352,248)	(1,086,834)
Cash used in investing activities	(2,536,832)	(2,511,827)	(944,906)
Change in cash during the period	(499,310)	(605,106)	2,206,889
Cash - Beginning of period	1,678,156	2,283,262	76,373
Cash - End of period	$ 1,178,846	$ 1,678,156	$ 2,283,262

Nature of Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2022
Nature of Operations [Abtsract]
NATURE OF OPERATIONS	1. NATURE OF OPERATIONS Versus Systems Inc. (the “Company”) was continued under the Business Corporations Act (British Columbia) effective January 2, 2007. The Company’s head office and registered and records office is 1558 West Hastings Street, Vancouver, BC, V6C 3J4, Canada. The Company’s common stock is traded on the NASDAQ under the symbol “VS”. The Company’s Unit A warrants are traded on NASDAQ under “VSSYW”. On November 9, 2022, the Company completed a one-for-15 reverse stock split of the Company’s common shares. All share and per share data are presented to reflect the reverse share split on a retroactive basis. The Company is engaged in the technology sector and has developed a proprietary prizing and promotions tool allowing game developers and creators of streaming media, live events, broadcast TV, games, apps, and other content to offer real world prizes inside their content. The ability to win prizes drives increased levels of consumer engagement creating an attractive platform for advertisers. In June 2021, the Company completed its acquisition of multimedia, production, and interactive gaming company Xcite Interactive, a provider of online audience engagement through its owned and operated XEO technology platform. The company partners with multiple professional sports franchises across Major League Baseball (MLB), National Hockey League (NHL), National Basketball Association (NBA) and the National Football League (NFL) as well as the Olympics, World Cup, and other global sporting events to drive in-stadium audience engagement as well as a software licensing business to drive audience engagement. These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. Different bases of measurement may be appropriate if the Company is not expected to continue operations for the foreseeable future. As of December 31, 2022, the Company has not achieved positive cash flow from operations and is not able to finance day to day activities through operations and as such, there is substantial doubt as to the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to attain profitable operations and generate funds therefrom and/or raise equity capital or borrowings sufficient to meet current and future obligations. These consolidated financial statements do not include any adjustments as to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2022
Basis of Presentation [abstract]
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION Statement of compliance These consolidated financial statements, including comparatives, have been prepared in accordance with International Financial Reporting Standards (collectively, IFRS) as issued by the International Accounting Standards Board (IASB) and Interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC). These consolidated financial statements were authorized for issue by the Board of Directors on March 29, 2023. Basis of measurement These consolidated financial statements have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value. In addition, these consolidated financial statements have been prepared using the accrual basis of accounting except for cash flow information. Functional and presentation currency These consolidated financial statements are presented in United States dollars, unless otherwise noted, which is the functional currency of the Company and its subsidiaries. Basis of consolidation These consolidated financial statements include the accounts of Versus Systems Inc. and its subsidiaries, from the date control was acquired. Control exists when the Company possesses power over an investee, has exposure to variable returns from the investee and has the ability to use its power over the investee to affect its returns. All inter-company balances and transactions, and any unrealized income and expenses arising from inter-company transactions, are eliminated on consolidation. For partially owned subsidiaries, the interest attributable to non-controlling shareholders is reflected in non-controlling interest. Adjustments to non-controlling interest are accounted for as transactions with owners and adjustments that do not involve the loss of control are based on a proportionate amount of the net assets of the subsidiary. Name of Subsidiary Place of Incorporation Proportion of Principal Activity Versus Systems (Holdco) Inc. United States of America 81.9 % Holding Company Versus Systems UK, Ltd. United Kingdom 81.9 % Sales Company Versus LLC United States of America 81.9 % Technology Company Xcite Interactive, Inc. United States of America 100.0 % Technology Company Significant Accounting Judgments, Estimates and Assumptions The preparation of these consolidated financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements. Estimates and assumptions are continually evaluated and are based on historical experience and management’s assessment of current events and other facts and circumstances that are considered to be relevant. Actual results could differ from these estimates. Significant assumptions about the future and other sources of estimation uncertainty that management has made at the end of the reporting year, that could result in a material adjustment to the carrying amounts of assets and liabilities in the event that actual results differ from assumptions made, relate to, but are not limited to, the following: i) Deferred income taxes Deferred tax assets, including those arising from un-utilized tax losses, require management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted. ii) Economic recoverability and probability of future economic benefits of intangible assets Management has determined that intangible asset costs which were capitalized may have future economic benefits and may be economically recoverable. Management uses several criteria in its assessments of economic recoverability and probability of future economic benefits including anticipated cash flows and estimated economic life. iii) Valuation of share-based compensation The Company uses the Black-Scholes Option Pricing Model for valuation of share-based compensation. Option pricing models require the input of subjective assumptions including expected price volatility, interest rate, and forfeiture rate. Input assumptions changes can materially affect the fair value estimate and the Company’s earnings and equity reserves. iv) Depreciation and Amortization The Company’s intangible assets and equipment are depreciated and amortized on a straight-line basis, taking into account the estimated useful lives of the assets and residual values. Changes to these estimates may affect the carrying value of these assets, net loss, and comprehensive income (loss) in future periods. v) Determination of functional currency The functional currency of the Company and its subsidiaries is the currency of the primary economic environment in which each entity operates. Determination of the functional currency may involve certain judgments to determine the primary economic environment. The functional currency may change if there is a change in events and conditions which determines the primary economic environment. vi) Revenue Recognition The Company’s contracts with customers may include promises to transfer multiple products and services. For these contracts, the Company accounts for individual performance obligations separately if they are capable of being distinct and distinct within the context of the contract. Determining whether products and services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the stand-alone selling price, for each distinct performance obligation. vii) Business combinations Judgement was used in determining whether the acquisition of Xcite Interactive, Inc. was a business combination or an asset acquisition. Estimates were made as to the fair value of assets and liabilities acquired. In certain circumstances, such as the valuation of equipment, intangible assets and goodwill acquired, the Company may rely on independent third-party valuators. The Company measured all the assets acquired and liabilities assumed at their acquisition-date fair values. The excess of the consideration paid over the acquisition-date fair values of the net assets acquired, was recognized as goodwill as of the acquisition date in business combination. viii) Subsequent Valuation of Intangibles Assets and Goodwill The Company uses three generally accepted principles to calculate the fair value of acquired intangible assets and goodwill from the Xcite acquisition: the income approach, the market approach, and the cost approach. The calculated fair value of each acquired asset is used in the Company’s annual impairment testing. Impairment loss is the amount by which the carrying amount of an asset or cash-generating unit (CGU) exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and its value in use. Value in use is the present value of the future cash flows expected to be derived from the asset or CGU.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Significant Accounting Policies [abstract]
SIGNIFICANT ACCOUNTING POLICIES	3. SIGNIFICANT ACCOUNTING POLICIES Basic and diluted loss per share Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common shareholders by the weighted average number of shares outstanding during the reporting periods. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of stock options and warrants, if dilutive. The number of additional shares is calculated by assuming that outstanding stock options and warrants were exercised and that the proceeds from such exercises were used to acquire common stock at the average market price during the reporting periods. Potentially dilutive options and warrants excluded from diluted loss per share as of December 31, 2022, totaled 7,081,173 (December 31, 2021 – 428,527). Property and equipment Property and equipment is recorded at cost less accumulated amortization and any impairments. Amortization is calculated based on the estimated residual value and estimated economic life of the specific assets using the straight-line method over the period indicated below: Asset Rate Computers Straight line, 3 years Right of use assets Shorter of useful life or lease term Financial instruments Classification The Company classifies its financial instruments in the following categories: at fair value through profit and loss (FVTPL), at fair value through other comprehensive income (loss) (FVTOCI), or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company’s business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL. Measurement The following table shows the classification of financial instruments: Financial assets/liabilities Classification IFRS 9 Cash FVTPL Receivables Amortized cost Restricted deposit Amortized cost Deposit Amortized cost Accounts payable and accrued liabilities Amortized cost Notes payable Amortized cost Financial assets and liabilities at amortized cost Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment. Financial assets and liabilities at FVTPL Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in profit or loss in the period in which they arise. Impairment of financial assets at amortized cost An ‘expected credit loss’ impairment model applies which requires a loss allowance to be recognized based on expected credit losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present value of the future cash flows associated with the asset, discounted at the financial asset’s original effective interest rate, either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period. In a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the impairment reversed does not exceed what the amortized cost would have been had the impairment not been recognized. Intangible assets excluding goodwill Derecognition of financial assets The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition are generally recognized in profit or loss. As at December 31, 2022, the Company does not have any derivative financial assets and liabilities. Intangible assets acquired separately are carried at cost at the time of initial recognition. Intangible assets acquired in a business combination and recognized separately from goodwill are initially recognized at their fair value at the acquisition date. Expenditure on research activities is recognized as an expense in the period in which it is incurred. Intangibles with a finite useful life are amortized and those with an indefinite useful life are not amortized. The useful life is the best estimate of the period over which the asset is expected to contribute directly or indirectly to the future cash flows of the Company. The useful life is based on the duration of the expected use of the asset by the Company and the legal, regulatory or contractual provisions that constrain the useful life and future cash flows of the asset, including regulatory acceptance and approval, obsolescence, demand, competition and other economic factors. If an income approach is used to measure the fair value of an intangible asset, the Company considers the period of expected cash flows used to measure the fair value of the intangible asset, adjusted as appropriate for Company-specific factors discussed above, to determine the useful life for amortization purposes. If no regulatory, contractual, competitive, economic or other factors limit the useful life of the intangible to the Company, the useful life is considered indefinite. Intangibles with a finite useful life are amortized on the straight-line method unless the pattern in which the economic benefits of the intangible asset are consumed or used up are reliably determinable. The Company evaluates the remaining useful life of intangible assets each reporting period to determine whether any revision to the remaining useful life is required. If the remaining useful life is changed, the remaining carrying amount of the intangible asset will be amortized prospectively over the revised remaining useful life. The Company’s intangible asset is amortized on a straight-line basis over 3 years. In the year development costs are incurred, amortization is based on a half year. Goodwill The Company allocates goodwill arising from business combinations to each cash generating unit (CGU) or group of CGUs that are expected to receive the benefits from the business combination. The carrying amount of the CGU or group of CGUs to which goodwill has been allocated is tested annually for impairment or when there is an indication that the goodwill may be impaired. Any impairment is recognized as an expense immediately. Should there be a recovery in the value of a CGU, any impairment of goodwill previously recorded is not subsequently reversed. Deferred financing costs Deferred financing costs consist primarily of direct incremental costs related to the Company’s public offering of its common stock completed in February 2022. Upon completion of the Company’s financing any deferred costs were offset against the proceeds. The Company incurred $174,813 during the year ended December 31, 2021, and $0 during the year ended December 31, 2022. Impairment of intangible assets excluding goodwill An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognized if, and only if, all of the following have been demonstrated: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) the intention to complete the intangible asset and use or sell it; (c) the ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) the ability to measure reliably the expenditure attributable to the intangible asset during its development. The amount initially recognized for internally-generated intangible assets is the sum of the costs incurred from the date when the intangible assets first meet the recognition criteria listed above. If no future economic benefit is expected before the end of the life of assets, the residual book value is expensed. Subsequent to initial recognition, internally-generated intangible assets are reported at cost. Where no internally-generated intangible asset can be recognized, development costs are recognized as an expense in the period in which it is incurred. At the end of each reporting period, the Company reviews the carrying amounts of its intangible assets to determine whether there is any indication that those assets have suffered impairment losses. If any such indication exists, the recoverable amount of the cash-generating unit (CGU) to which the asset belongs is estimated in order to determine the extent of the impairment losses (if any). Where a reasonable and consistent basis of allocation can be identified, corporate assets (assets other than goodwill that contribute to the future cash flows of both the CGU under review and other CGUs) are also allocated to individual CGUs, or otherwise they are allocated to the smallest group of CGUs for which a reasonable and consistent allocation basis can be identified. Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or CGU) is estimated to be less than its carrying amount, the carrying amount of the asset (or CGU) is reduced to its recoverable amount. Where impairment losses subsequently reverse, the carrying amount of the asset (or CGU) is increased to the revised estimate of its recoverable amount, such that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment losses been recognized for the asset (or CGU) in prior years. A reversal of impairment losses is recognized immediately in profit or loss. Income taxes Tax expense recognized in profit or loss comprises the sum of current tax and deferred tax not recognized in other comprehensive income or directly in equity. Current income tax Current income tax assets and/or liabilities comprise those claims from, or obligations to, fiscal authorities relating to the current or prior reporting periods that are unpaid at the reporting date. Current tax is payable on taxable profit, which differs from profit or loss in the consolidated financial statements. Calculation of current tax is based on tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax Deferred income taxes are calculated based on temporary differences between the carrying amounts of assets and liabilities and their tax bases. Deferred tax assets and liabilities are calculated, without discounting, at tax rates that are expected to apply to their respective period of realization, provided they are enacted or substantively enacted by the end of the reporting period. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income. Deferred tax assets and liabilities are offset only when the Company has a right and intention to offset current tax assets and liabilities from the same taxation authority. Changes in deferred tax assets or liabilities are recognized as a component of tax income or expense in profit or loss, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively. Leases Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the Company. Assets and liabilities arising from a lease are initially measured on a present value basis. Right-of-use assets are measured at cost comprising the following: - the amount of the initial measurement of lease liability; - any lease payments made at or before the commencement date less any lease incentives received; - any initial direct costs; and - restoration costs. The Company assesses whether a contract is or contains a lease, at inception of a contract. The Company recognizes a right-of-use asset and a corresponding lease liability with respect to all lease agreements in which it is the lessee. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the Company uses its incremental borrowing rate. Lease liability The lease liability is subsequently measured by increasing its carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect lease payments made. The right-of-use asset is depreciated over the shorter of the lease term and the useful life of the underlying asset. The Company applies IAS 36, Impairment of Assets, to determine whether the asset is impaired and account for any identified impairment loss. As a practical expedient, IFRS 16 permits a lease not to separate non-lease components, and instead account for any lease and associated non-lease components as a single arrangement. The Company has not used this practical expedient, and accordingly allocates the consideration in the contract to lease and non-lease components based on the stand-alone price of the lease component and aggregate stand-alone price of the non-lease components. Variable rents that do not depend on an index or rate are not included in the measurement of the lease liability and the right-of-use asset. The related payments are recognized as an expense in the period in which the event or condition that triggers those payments occurs and are presented as such in the statements of income and comprehensive income. Provisions A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. Government grants Government grants are recognized when there is reasonable assurance that the Company will comply with any conditions attached to the grant and the grant will be received. Government grants are recognized in profit or loss to offset the corresponding expenses on a systematic basis over the periods in which the Company recognizes expenses for the related costs for which the grants are intended to compensate, which in the case of grants related to assets requires setting up the grant as deferred income or deducting it from the carrying amount of the asset. Non-controlling interest Non-controlling interest in the Company’s less than wholly owned subsidiary is classified as a separate component of equity. On initial recognition, non-controlling interest is measured at the fair value of the non-controlling entity’s contribution into the related subsidiary. Subsequent to the original transaction date, adjustments are made to the carrying amount of non-controlling interest for the non-controlling interest’s share of changes to the subsidiary’s equity. Changes in the Company’s ownership interest in a subsidiary that do not result in a loss of control are recorded as equity transactions. The carrying amount of non-controlling interest is adjusted to reflect the change in the non-controlling interest’s relative interest in the subsidiary, and the difference between the adjustment to the carrying amount of non-controlling interests and the Company’s share of proceeds received and/or consideration paid is recognized directly in equity and attributed to owners of the Company. Valuation of equity units issued in private placements The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in private placements is determined to be the more easily measurable component and are valued at their fair value. The balance, if any, is allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in the warrant reserve. Warrants issued in equity financing transactions The Company engages in equity financing transactions to obtain funds necessary to continue operations. These equity financing transactions may involve issuance of common shares or units. Each unit comprises a certain number of shares and a certain number of warrants. Depending on the terms and conditions of each equity financing transaction, the warrants are exercisable into additional common shares at a price prior to expiry as stipulated by the transaction. Warrants that are part of units are assigned a value based on the residual value, if any, and included in reserves. As of February 1, 2021, the warrants were considered a derivative liability since the obligation to issue shares was not fixed in the Company’s functional currency. The derivative warrant liability was measured as fair value at issue with subsequent changes recognized in the consolidated statement of loss and comprehensive loss. A $9,743,659 warrant derivative loss was recorded in the consolidated statement of loss and comprehensive loss beginning February 1, 2021 when the Company changed its functional currency. As of December 31, 2022 the associated warrants have expired and the remaining balance of the warrant liability is $0. The Company uses the Black-Scholes Option Pricing Model for valuation of share-based payments and derivative financial assets (e.g. investments in warrants). Option pricing models require the input of subjective assumptions including expected price volatility, interest rates, and forfeiture rates. Changes in the input assumptions can materially affect the fair value estimate and the Company’s earnings and equity reserves. Share-based compensation The Company grants stock options to acquire common shares of the Company to directors, officers, employees and consultants. An individual is classified as an employee when the individual is an employee for legal or tax purposes, or provides services similar to those performed by an employee. The fair value of stock options is measured on the date of grant, using the Black-Scholes option pricing model, and is recognized over the vesting period. Consideration paid for the shares on the exercise of stock options is credited to capital stock. In situations where equity instruments are issued to non-employees and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received. Revenue recognition In general, the Company recognizes revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the Company, where there is evidence of an arrangement, when the selling price is fixed or determinable, and when specific criteria have been met or there are no significant remaining performance obligations for each of the Company’s activities as described below. Foreseeable losses, if any, are recognized in the year or period in which the loss is determined. The Company earns revenue in three primary ways: 1) the sales of software-as-a-service (SAAS) from its interactive production software platform, 2) development and maintenance of custom-built software or other professional services, or 3) the sale of advertising. The Company recognizes SAAS revenues from its interactive production sales over the life of the contract as its performance obligations are satisfied. Payment terms vary by contract and can be periodic or one-time payments. The Company recognizes revenues received from the development and maintenance of custom-built software and other professional services provided upon the satisfaction of its performance obligation in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. Performance obligations can be satisfied either at a single point in time or over time. For those performance obligations that are satisfied at a single point in time, the revenue is recognized at that time. For each performance obligation satisfied over time, the Company recognizes revenue by measuring the progress toward complete satisfaction of that performance obligation. For revenues received from the sales of advertising, the Company is deemed the agent in its revenue agreements. The Company does not own or obtain control of the digital advertising inventory. The Company recognizes revenues upon the achievement of agreed-upon performance criteria for the advertising inventory, such as a number of views, or clicks. As the Company is acting as an agent in the transaction, the Company recognizes revenue from sales of advertising on a net basis, which excludes amounts payable to partners under the Company’s revenue sharing agreements. The Company’s contracts with customers may include promises to transfer multiple products and services. For these contracts, the Company accounts for individual performance obligations separately if they are capable of being distinct and distinct within the context of the contract. Determining whether products and services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the stand-alone selling price, for each distinct performance obligation. As the Company’s performance obligations are satisfied within 12 months, the Company has elected the practical expedients under IFRS 15, which allows the Company not to record any significant financing component as a result of financing any of its arrangements and not to capitalize cost incurred to obtain a contract. Deferred revenue Revenue recognition of sales is recorded on a monthly basis upon delivery or as the services are provided. Cash received in advance for services are recorded as deferred revenue based on the proportion of time remaining under the service arrangement as of the reporting date. Foreign exchange The functional currency is the currency of the primary economic environment in which the entity operates and has been determined for each entity within the Company. The functional currency for the Company and its subsidiaries is the United States dollar. The functional currency determinations were conducted through an analysis of the consideration factors identified in IAS 21, The Effects of Changes in Foreign Exchange Rates. Foreign currency transactions in currencies other than the United States dollar are recorded at exchange rates prevailing on the dates of the transactions. Foreign currency transaction gains and losses are generally recognized in profit or loss and presented within gain (loss) on foreign exchange. At the end of each reporting period, the monetary assets and liabilities of the Company and its subsidiaries that are denominated in foreign currencies are translated at the rate of exchange at the date of the statement of financial position. Non-monetary assets and liabilities that are denominated in foreign currencies are translated at historical rates. Revenues and expenses that are denominated in foreign currencies are translated at the exchange rates approximating those in effect on the date of the transactions. Foreign currency translation gains and losses are recognized in other comprehensive income and accumulated in equity within the currency translation reserve. Comprehensive Income (Loss) Comprehensive income (loss) consists of net income (loss) and other comprehensive income (loss) and represents the change in shareholders’ equity (deficit) which results from transactions and events from sources other than the Company’s shareholders. Comprehensive loss differs from net loss for the year ended December 31, 2022 due to the effects of foreign translation gains and losses. Net loss is the same as comprehensive loss for the year ended December 31, 2021. Net loss differs from comprehensive loss for the year ending December 31, 2020 as a result of the change in presentation and functional currency.

Change in Functional and Presen

Change in Functional and Presentation Currency	12 Months Ended
	Dec. 31, 2022
Change in Functional and Presentation Currency [abstract]
CHANGE IN FUNCTIONAL AND PRESENTATION CURRENCY	4. CHANGE IN FUNCTIONAL AND PRESENTATION CURRENCY The Company changed its functional currency from the Canadian dollar (CAD) to the United States dollar (USD) as of February 1, 2021. The change in functional currency coincided with the January 2021 initial public offering and listing on the Nasdaq. Considering Versus’ business activities, comprised primarily of United States dollar revenue and expenditures as well as United States dollar denominated financings, management determined that the functional currency of the Company is the United States dollar. All assets, liabilities, share capital, and other components of shareholders’ equity (deficit) were translated into United States dollars at the exchange rate at the date of change. These changes have been accounted for prospectively. Concurrent with the change in functional currency, on February 1, 2021, the Company changed its presentation currency from the Canadian dollar to the United States dollar. This change in presentation currency is to better reflect the Company’s business activities, comprised primarily of United States dollar transactions. The consolidated financial statements for all periods presented have been translated into the new presentation currency in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates. The consolidated statements of loss and comprehensive loss have been translated into the presentation currency using the average exchange rates prevailing during each quarterly reporting period. All assets and liabilities previously reported in Canadian dollars have been translated into United States dollars as at February 1, 2021 using the period-end noon exchange rates of 0.782 CAD/USD. As a practical measure, the comparative shareholders’ equity (deficit) balances were translated at the February 1, 2021 exchange rate of 1.2824 CAD/USD. All resulting translation exchange differences have been recognized within other comprehensive income in the foreign currency translation reserve. The effect of applying different exchange rates for the change in functional currency and presentation currency have been included as a reconciling item within the statement of changes in shareholders’ equity (deficit) as at February 1, 2021.

Receivables

Receivables	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
RECEIVABLES	5. RECEIVABLES As of December 31, 2022, accounts receivable consists of customer receivables of $46,592 (net an allowance for doubtful accounts of $6,100) and GST receivable of $14,157. As of December 31, 2021, accounts receivable consists of customer receivables of $90,808 (net an allowance for doubtful accounts of $11,500) and GST receivable of $32,809.

Restricted Deposit

Restricted Deposit	12 Months Ended
	Dec. 31, 2022
Restricted Deposit [abstract]
RESTRICTED DEPOSIT	6. RESTRICTED DEPOSIT As at December 31, 2022, restricted deposits consisted of $8,489 (December 31, 2021 - $9,068) held in a guaranteed investment certificate as collateral for a corporate credit card.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2022
Property and Equipment [Abstract]
PROPERTY AND EQUIPMENT	7. PROPERTY AND EQUIPMENT Computers Right of Use Asset Total ($) ($) ($) Cost At December 31, 2020 88,329 936,958 1,025,287 Additions 108,974 - 108,974 Foreign currency adjustment (15,913 ) (23,553 ) (39,466 ) At December 31, 2021 181,390 913,405 1,094,795 Additions 65,329 - 65,329 At December 31, 2022 246,719 913,405 1,160,124 Accumulated amortization At December 31, 2020 82,286 449,191 531,477 Amortization for the year 30,793 205,580 236,373 At December 31, 2021 113,079 654,771 767,850 Amortization for the period 39,667 179,766 219,433 At December 31, 2022 152,746 834,537 987,283 Carrying amounts At December 31, 2020 6,044 475,817 481,861 At December 31, 2021 68,311 258,634 326,945 At December 31, 2022 93,973 78,868 172,841

Non-Controlling Interest in Ver

Non-Controlling Interest in Versus LLC	12 Months Ended
	Dec. 31, 2022
Non-Controlling Interest in Versus LLC Disclosure [Abstract]
NON-CONTROLLING INTEREST IN VERSUS LLC	8. NON-CONTROLLING INTEREST IN VERSUS LLC As of December 31, 2018, the Company held a 41.3% ownership interest in Versus LLC, a privately held limited liability company organized under the laws of the state of Nevada. The Company consolidates Versus LLC as a result of having full control over the voting shares. Versus LLC is a technology company that is developing a business-to-business software platform that allows video game publishers and developers to offer prize-based matches of their games to their players. On May 21, 2019, the Company acquired an additional 25.2% interest in Versus LLC in exchange for 38,268 common shares of the Company and 19,134 share purchase warrants. The common shares and the share purchase warrants were determined to have a fair value of $1,403,675 and $116,595, respectively. As a result, the Company increased its ownership interest to 66.5% and recorded the excess purchase price over net identifiable liabilities of $3,575,884 against reserves. The effect on non-controlling interest was a reduction of $2,053,199. On June 21, 2019, the Company acquired an additional 0.3% interest in Versus LLC in exchange for 189 common shares of the Company and 95 share purchase warrants. The common shares and the share purchase warrants were determined to have a fair value of $6,906 and $2,527, respectively. As a result, the Company increased its ownership interest to 66.8% and recorded the excess purchase price over net identifiable assets of $26,448 against reserves. The effect on non-controlling interest was a reduction of $19,433. On March 1, 2022, the Company acquired an additional 15.1% interest in Versus LLC in exchange for 11,441 common shares of the Company. The common shares were determined to have a fair value of $186,294. As a result, the Company increased its ownership interest to 81.9% and recorded the excess purchase price over net identifiable assets of $4,562,631 against reserves. The effect on non-controlling interest was a reduction of $4,376,337. The following table presents summarized financial information before intragroup eliminations for the non-wholly owned subsidiary as of December 31, 2022, December 31, 2021 and December 31, 2020. 2022 2021 2020 Non-controlling interest percentage 18.1% 33.2% 33.2% ($) ($) ($) Assets Current 1,011,636 1,488,892 779,123 Non-current 2,910,990 2,300,268 2,289,645 3,922,626 3,789,160 3,068,768 Liabilities Current 518,701 763,970 1,020,192 Non-current 39,774,321 30,661,143 17,329,272 40,293,022 31,425,113 18,349,464 Net liabilities (36,370,396 ) (27,635,953 ) (15,280,696 ) Non-controlling interest (6,383,129 ) (8,621,581 ) (5,193,701 ) Net loss (10,090,734 ) (17,847,892 ) (6,911,040 ) Net loss attributed to non-controlling interest (2,137,885 ) (3,448,820 ) (1,464,660 )

Acquisition of Xcite Interactiv

Acquisition of Xcite Interactive, Inc.	12 Months Ended
	Dec. 31, 2022
Acquisition of Xcite Interactive, Inc. [abstract]
ACQUISITION OF XCITE INTERACTIVE, INC.	9. ACQUISITION OF XCITE INTERACTIVE, INC. A) Summary of the Acquisition On June 3, 2021, the Company closed its acquisition of all the issued and outstanding common shares of Xcite Interactive Inc. (Xcite) in exchange for common shares of the Company. Pursuant to the terms of the acquisition, the Company acquired all the issued and outstanding Xcite common shares in consideration for the issuance of 0.0234 of a common shares of the Company for each Xcite common share. The Company issued a total of 100,461 common shares with a fair value of $10.7 million, based on the June 3, 2021 closing share price of $101.40. The Company issued an additional 2,917 shares on July 26, 2021, related to the Payment Protection Program (PPP) loan escrow account that was included in the Xcite debt at the time of the acquisition. In addition, $109,360 of cash was awarded to non-accredited investors of Xcite on June 3, 2021, and additional $2,865 on July 26, 2021. The acquisition was accounted for using the acquisition method pursuant to IFRS 3, “Business Combinations”. Under the acquisition method, assets and liabilities are measured at their estimated fair value on the date of acquisition with the exception of income tax, stock-based compensation, lease liabilities and ROU assets. The total consideration was allocated to the tangible and intangible assets acquired and liabilities assumed. The following table summarizes the details of the consideration and the recognized amounts of assets acquired and liabilities assumed at the date of the acquisition. B) Consideration Common shares $ 12,890,029 Cash 112,225 Working capital adjustment (163,902 ) PPP shares 346,031 Total Consideration $ 13,184,383 Identifiable Assets Acquired and Liabilities Assumed Cash $ 27,124 Accounts Receivable 37,719 Property, Plant and Equipment 34,496 Intangible Assets 7,140,000 Other Assets 12,409 Accounts Payable and Accrued Liabilities (524,853 ) Other Liabilities (123,171 ) Total Identifiable Assets $ 6,603,724 Goodwill $ 6,580,659 Goodwill recognized is attributable to the synergies expected to be achieved. Goodwill is not deductible for tax purposes. C) Impairment of Goodwill and Intangible Assets The Company conducts an annual impairment analysis in accordance with IAS 36 Impairment of Assets. A number of factors influenced the performance of Xcite Interactive in 2022 and beyond, including reduced revenue projections, the time and cost involved in creating custom games, the departure of key Xcite employees, and the competitive landscape of the fan engagement industry. As a result, the Company engaged a third-party to conduct an impairment analysis as of December 31, 2022. The analysis determined that the recoverable amount was $4,425,000 resulting in an impairment of $8,254,000. The goodwill balance of $6,580,660 was written down to $0. The additional impairment of $1,673,340 was attributed on a pro-rata basis to the intangible assets related the Xcite acquisition. These assets include customer relationships, tradename, and developed technology. D) Revenue and Profit Contribution The acquired business contributed revenues of $988,436 for the year ended December 31, 2022.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2022
Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	10. INTANGIBLE ASSETS Intangible assets are comprised of a business-to-business software platform that allows video game publishers and developers to offer prize-based matches of their games to their players. The Company continues to develop new apps, therefore additional costs were capitalized during the year ended December 31, 2022. Software Customer Relationships Tradename Developed Technology Total Cost At December 31, 2020 9,914,104 - - - 9,914,104 Foreign currency adjustment (47,444 ) (47,444 ) Additions 2,352,248 4,840,000 750,000 1,550,000 9,492,248 At December 31, 2021 12,218,908 4,840,000 750,000 1,550,000 19,358,908 Additions 2,496,621 - - - 2,496,621 Impairments - (1,194,377 ) (235,555 ) (243,407 ) (1,673,340 ) At December 31, 2022 14,748,072 3,645,623 514,445 1,306,593 20,214,732 Accumulated amortization At December 31, 2020 8,176,688 - - - 8,176,688 Amortization 1,304,991 403,333 - 301,389 2,009,713 At December 31, 2021 9,481,679 403,333 - 301,389 10,186,401 Amortization 1,729,326 691,430 - 516,667 2,937,423 At December 31, 2022 11,334,223 1,037,144 - 775,000 13,156,368 Carrying amounts At December 31, 2020 2,256,903 - - - 1,737,416 At December 31, 2021 2,636,555 4,494,286 750,000 1,291,667 9,172,507 At December 31, 2022 3,403,849 2,608,479 514,445 531,593 7,058,366

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 31, 2022
Accounts Payable and Accrued Liabilities [abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	11. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES The Company’s accounts payable and accrued liabilities are comprised of the following: December 31, 2022 December 31, ($) ($) Accounts payable (Note 12) 138,276 386,030 Due to related parties (Note 12 and Note 14) 304,623 302,883 Accrued liabilities (Note 12) 79,113 143,486 522,012 832,399

Notes Payable _ Related Party

Notes Payable – Related Party	12 Months Ended
	Dec. 31, 2022
Notes Payable – Related Party Disclosure [Abstract]
NOTES PAYABLE – RELATED PARTY	12. NOTES PAYABLE – RELATED PARTY During the year ended December 31, 2022, the Company repaid $64,550 of principal. As at December 31, 2022, the Company had recorded $23,456 in accrued interest which was included in accounts payable and accrued liabilities. During the year ended December 31, 2021, the Company exchanged 14,357 shares of common stock in exchange for a principal reduction of debt in the amount of $1,483,738 and $131,320 of accrued interest. The Company recorded a loss on the conversion of $116,152. In addition, the Company repaid $462,228 of principal. As at December 31, 2021, the Company had recorded $38,301 in accrued interest which was included in accounts payable and accrued liabilities. During the year ended December 31, 2022, the Company recorded finance expense of $60,770 (December 31, 2021 - $225,196), related to bringing the notes to their present value. Amount ($) Balance at December 31, 2020 4,528,549 Proceeds - Repayments (2,058,720 ) Contribution benefit - Finance expense 225,196 Foreign exchange adjustment 91,158 Balance, December 31, 2021 2,786,183 Foreign currency adjustment (177,690 ) Repayments (64,550 ) Finance expense 60,770 Balance, December 31, 2022 2,604,713 Current 2,604,713 Non-current 0

Share Capital and Reserves

Share Capital and Reserves	12 Months Ended
	Dec. 31, 2022
Share Capital and Reserves [abstract]
SHARE CAPITAL AND RESERVES	13. SHARE CAPITAL AND RESERVES a) Authorized share capital We are authorized to issue an unlimited number of Class A Shares. The Class A Shares do not have any special rights or restrictions attached. As of December 31, 2022, there were 338 Class A Shares issued and outstanding. b) Issued share capital During the year ended December 31, 2022, the Company: i) Issued 291,667 units at a price of $24.00 per unit per unit for total proceeds of $7,000,000. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027. In connection with the offering, the Company incurred $900,720 in issuance costs as part of the transaction. ii) Issued 11,441 shares, which were converted from Versus Holdco shares. iii) Issued 39,375 shares at a price of $22.20 per unit for total proceeds of $874,125 as a result of the underwriter exercising the overallotment. iv) Issued 4,196 shares related to the Xcite acquisition and the vesting of key employee shares. v) Issued 276,334 units at a price of $7.80 per unit for total proceeds of $2,155,195. The offering consisted of 140,000 common shares and 136,334 pre-funded warrants. In connection with the offering, the Company incurred $313,482 in issuance costs as part of the transaction. vi) Issued 412,293 shares at $2.72 per share in a private placement offering for total proceeds of $1,119,373. vii) Issued 2,100,000 units at a price of $1.00 per unit for total proceeds of $2,099,866. The offering consisted of 300,000 common shares and 1,800,000 pre-funded warrants. In connection with the offering, the Company incurred $522,460 in issuance costs as part of the transaction. Escrow At December 31, 2022, 21 common shares (December 31, 2021 – 21) of the Company are held in escrow due to misplaced share certificates originally issued to three individual shareholders. During the year ended December 31, 2021, the Company: i) Issued 100,461 units at a price of $101.40 per unit in connection with the acquisition of Xcite. ii) Issued 98,134 units at a price of $112.50 per unit per unit for total proceeds of $11,040,000. Each unit consisted of one common share, one Unit A warrant and one Unit B warrant. Unit A warrants allow the purchaser to purchase one common share at $112.50 per share until January 20, 2026. Unit B warrants allow the purchaser to purchase one common share at $112.50 per share until January 20, 2026. In connection with the offering, the Company incurred $1,524,439 in issuance costs as part of the transaction. iii) Issued 103,559 common shares pursuant to exercise of 95,689 warrants and 7,870 stock options for total proceeds of $6,735,254. iv) Issued 14,357 units consisting of one share of common share and one Unit A warrant and one Unit B warrant in exchange for the forgiveness of $1,615,058 of debt and accrued interest. v) Issued 1,954 shares of the Company’s common stock with a value of $206,614 to a third party in exchange for services (included in professional fees). vi) Issued 2,916 shares related to the PPP loan escrow account that was included in the Xcite debt at the time of the acquisition. During the year ended December 31, 2020, the Company: i) Issued 10,000 units at a price of $45.30 per unit for total proceeds of $453,000. Each unit consisted of one common share and a one half share purchase warrant for each share purchased. Each whole warrant entitles the holder to purchase one additional common share at a price of $70.65 until February 17, 2021. ii) Issued 11,502 units at a price of $44.25 per unit for total proceeds of $508,969. Each unit consisted of one common share and one share purchase warrant for each share purchased. iii) Issued 41,667 units at a price of $45.75 per unit for total proceeds of $1,906,250. Each unit consisted of one common share and a one half share purchase warrant for each share purchased. iv) Entered into a Mutual Investment Agreement with Animoca Brands Inc. (Animoca) in which the Company issued 12,103 shares of the Company’s common stock with a value of $502,414 in exchange for 4,327,421 shares of Animoca common stock. On the same date, the Company issued an additional 5,939 shares of the Company’s common stock with a value of $251,169 to Animoca in exchange for services (included in professional fees). The Company subsequently sold all of its shares of Anomica and recognized a loss of $378,718. v) Issued 70,660 common shares pursuant to exercise of 70,410 warrants and 250 stock options for total proceeds of $3,552,473. c) Stock options The Company may grant incentive stock options to its officers, directors, employees, and consultants. The Company has implemented a rolling Stock Option Plan (the “Plan”) whereby the Company can issue up to 10% of the issued and outstanding common shares of the Company. Options have a maximum term of ten years and vesting is determined by the Board of Directors. A continuity schedule of outstanding stock options is as follows: Number Outstanding Weighted Average Exercise Price ($) Balance – December 31, 2020 90,255 55.50 Granted 64,015 73.05 Exercised (7,869 ) 49.80 Forfeited (16,950 ) 50.85 Balance –December 31, 2021 129,451 63.60 Granted 104,520 6.19 Exercised - - Forfeited (6,183 ) 92.81 Balance – December 31, 2022 227,788 37.13 During the year ended December 31, 2022, 104,520 stock options were granted by the Company. During the year ended December 31, 2022, the Company recorded share-based compensation of $1,567,583 (December 31, 2021 - $2,145,928) relating to options vested during the period. During the year ended December 31, 2021, 64,015 stock options were granted by the Company. During the year ended December 31, 2021, the Company recorded share-based compensation of $2,145,928 relating to options vested during the period. During the year ended December 31, 2020, 31,339 stock options were granted by the Company. During the year ended December 31, 2020, the Company recorded share-based compensation of $1,049,135 relating to options vested during the year. The Company used the following assumptions in calculating the fair value of stock options for the period ended: December 31, December 31, Risk-free interest rate 2.14% – 4.03% 0.04% - 0.47% Expected life of options 5.0 years 5.0 years Expected dividend yield Nil Nil Volatility 96.90% – 112.40% 102% - 128% At December 31, 2022, the Company had incentive stock options outstanding as follows: Expiry Date Options Outstanding Exercise Price Weighted Average ($) (years) June 6, 2023 937 85.50 0.93 September 4, 2023 855 44.55 1.18 April 2, 2024 7,129 37.80 1.76 June 27, 2024 417 38.40 1.99 September 27, 2024 20,005 67.95 2.24 October 22, 2024 834 60.45 2.31 July 24, 2025 16,139 44.70 3.07 July 31, 2025 11,080 44.70 3.07 August 10, 2025 833 44.70 3.11 November 19, 2025 1,024 68.85 2.39 June 1, 2026 3,788 105.60 3.97 June 29, 2026 21,967 84.75 3.97 August 19, 2026 38,260 63.00 3.20 March 18, 2027 1,500 19.80 4.00 May 10, 2027 800 11.85 4.00 August 17, 2027 99,980 6.00 4.80 September 20, 2027 2,240 3.45 4.80 227,788 37.13 3.82 d) Share purchase warrants A continuity schedule of outstanding share purchase warrants is as follows: Number Outstanding Weighted Average Exercise Price ($) Balance – December 31, 2020 179,508 54.15 Exercised (72,581 ) 63.15 Expired (32,830 ) 63.15 Issued 224,979 112.50 Balance – December 31, 2021 299,077 102.45 Exercised - - Expired (186,586 ) 96.30 Issued 5,166,044 3.42 Balance – December 31, 2022 (1) 5,278,535 5.74 (1) Unit A warrant balance is 1,687,341 as of December 31, 2022; however, table above reflects 15:1 post-consolidated common shares to be issued and exercise price upon the exercise of the warrants. During the year ended December 31, 2022, the Company: i) Completed a public offering on February 28, 2022, and issued 291,669 units at a price of $24.00 per unit per unit for total proceeds of $7,000,000. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027. ii) Issued 39,375 units on March 24, 2022, at a price of $22.20 per unit for total proceeds of $874,125 because the underwriter exercised its overallotment option. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027. iii) Issued 414,500 warrants on July 18, 2022, to purchase common shares, each exercisable for one common share at an exercise price of $7.80 per share in an offer to an investor. iv) Completed a public offering on December 9, 2022 and issued 2,100,000 units for total proceeds of $2,099,866. Each unit consists of (1) either (a) one common share or (b) one pre-funded warrant to purchase one common share and (2) two warrants to purchase one common share each, at a public offering price of $1.00 per unit. The unit will have an exercise price of $1.10 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. An additional 220,500 warrants were provided to placement agents with an exercise price of $1.25 per share. During the year ended December 31, 2021, the Company: i) On January 21, 2021, Company completed a public offering and issued 98,134 units at a price of $112.50 per unit for total proceeds of $11,040,000. Each unit consisted of one common share, one Unit A warrant and one Unit B warrant, each to purchase one common share for a total of 196,267 warrants issued at $112.50 per share until January 21, 2023. ii) On January 21, 2021, the Company entered into a debt exchange agreement and exchanged 14,357 shares of common stock for the reduction of $1,615,058 of debt and accrued interest. As part of the agreement the Company also issued 14,357 Unit A warrants and 14,357 Unit B warrants issued at $112.50 per share until January 21, 2023. During the year ended December 31, 2020, the Company: i) On February 17, 2020, the Company completed a unit private placement which included 10,000 share purchase warrants exercisable at $72.45 per share for a period of two years. The share purchase warrants were determined to have a fair value of $ Nil ii) On July 17, 2020, the Company completed a unit private placement which included 11,502 share purchase warrants exercisable at $70.65 per share for a period of two years. The share purchase warrants were determined to have a fair value of $41,155 using the residual value method. iii) On November 17, 2020, the Company completed a unit private placement which included 41,667 share purchase warrants exercisable at $73.35 per share for a period of two years. The Company used the following assumptions in calculating the fair value of the warrants for the period ended: December 31, December 31, Risk-free interest rate 3.99% - 4.22% 0.25 % Expected life of warrants 3.06 – 5.05 years 0.7 - 1.76 years Expected dividend yield Nil Nil Volatility 119% – 124.9% 75 % Weighted average fair value per warrant $ 0.26 $ 3.38 At December 31, 2022, the Company had share purchase warrants outstanding as follows: Expiry Date Warrants Outstanding Exercise Price Weighted Average Remaining Life ($) (years) January 20, 2026 (1) 112,491 112.50 3.06 February 28, 2027 331,044 28.80 4.16 December 6, 2027 220,500 1.25 4.93 December 9, 2027 4,200,000 1.10 4.94 January 18, 2028 414,500 7.80 5.05 5,278,535 5.74 4.45 (1) Unit A warrant balance is 1,687,341 as of December 31, 2022; however, table above reflects 15:1 post-consolidated common shares to be issued and exercise price upon the exercise of the warrants.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS The following summarizes the Company’s related party transactions, not disclosed elsewhere in these consolidated financial statements, during the twelve months ended December 31, 2022 and 2021. Key management personnel includes the Chief Executive Officer (CEO), Chief Financial Officer (CFO) and certain directors and officers and companies controlled or significantly influenced by them. Key Management Personnel 2022 2021 ($) ($) Short-term employee benefits paid or accrued to the CEO of the Company, including share-based compensation vested for incentive stock options and performance warrants. 350,657 335,430 Short-term employee benefits paid or accrued to the CFO of the Company, including share-based compensation vested for incentive stock options and performance warrants. 363,291 447,710 Short-term employee benefits paid or accrued to a member of the advisory board of the Company, including share-based compensation vested for incentive stock options and performance warrants. 215,038 215,706 Short-term employee benefits paid or accrued to the Chief Technology Officer of the Company, including share-based compensation vested for incentive stock options and performance warrants. 306,441 289,290 Short-term employee benefits paid or accrued to a Director of the Company, including share-based compensation vested for incentive stock options and performance warrants. 293,585 - Short-term employee benefits paid or accrued to the Chief People Officer of the Company, including share-based compensation vested for incentive stock options and performance warrants. 205,681 - Short-term employee benefits paid or accrued to other directors and officers of the Company, including share-based compensation vested for incentive stock options and performance warrants. 426,153 666,586 Total 2,160,846 1,954,722 Other Related Party Payments Office sharing and occupancy costs of $64,741 (December 31, 2021 - $67,012) were paid or accrued to a corporation that shares management in common with the Company. Amounts Outstanding a) At December 31, 2022, a total of $304,623 (December 31, 2021 - $302,883) was included in accounts payable and accrued liabilities owing to officers, directors, or companies controlled by them. These amounts are unsecured and non-interest bearing (Note 11). b) At December 31, 2022, a total of $2,604,713 (December 31, 2021 - $2,786,183) of notes are payable to a director of the Company (Note 12).

Financial Instruments and Risk

Financial Instruments and Risk Management	12 Months Ended
	Dec. 31, 2022
Financial Instruments and Risk Management Disclosure [Abstract]
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT	15. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Financial risk management Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are: Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and Level 3 – Inputs that are not based on observable market data. The Board of Directors has overall responsibility for the establishment and oversight of the Company’s risk management framework. The Company’s financial instruments consist of cash, receivables, restricted deposit, accounts payable and accrued liabilities and notes payable. The fair value of cash, receivables, accounts payable and accrued liabilities approximate their book values because of the short-term nature of these instruments. The fair value of notes payable approximates its book value as it was discounted using a market rate of interest. Credit risk Credit risk is the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its payment obligations. The Company has no material counterparties to its financial instruments with the exception of the financial institutions which hold its cash. The Company manages its credit risk by ensuring that its cash is placed with a major financial institution with strong investment grade ratings by a primary ratings agency. The Company’s receivables consist of goods and services due from customers and tax due from the Canadian government. Financial instrument risk exposure The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board approves and monitors the risk management processes. Liquidity risk The Company’s cash is invested in business accounts which are available on demand. The Company has raised additional capital during the year ended December 31, 2022. Interest rate risk The Company’s bank account earns interest income at variable rates and the notes payable bear interest at the prime lending rate. The fair value of its portfolio is relatively unaffected by changes in short-term interest rates. A 1% change in interest rates would have no significant impact on profit or loss for the year period ended December 31, 2022. Foreign exchange risk Foreign currency exchange rate risk is the risk that the fair value of financial instruments or future cash flows will fluctuate because of changes in foreign exchange rates. The Company operates in Canada and the United States. The Company was exposed to the following foreign currency risk as at December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 ($) ($) Cash 245,858 162,135 Accounts payable and accrued liabilities (93,630 ) (142,726 ) 152,228 19,409 As at December 31, 2022, with other variables unchanged, , a +/- 10% change in the United States dollar to Canadian dollar exchange rate would impact the Company’s net loss by $15,200 (December 31, 2021 - $1,900).

Management of Capital

Management of Capital	12 Months Ended
	Dec. 31, 2022
Management of Capital [Abstract]
MANAGEMENT OF CAPITAL	16. Management of Capital The Company manages its capital structure and makes adjustments to it, based on the funds available to the Company. Capital consists of items within equity (deficit). The Board of Directors does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company’s management to sustain future development of the business. The Company is not subject to any externally imposed capital requirements. The Company remains dependent on external financing to fund its activities. In order to sustain its operations, the Company will spend its existing cash on hand and raise additional amounts as needed until the business generates sufficient revenues to be self-sustaining. Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable. In order to maximize ongoing corporate development efforts, the Company does not pay out dividends. The Company’s investment policy is to keep its cash treasury invested in certificates of deposit with major financial institutions. There have been no changes to the Company’s approach to capital management during the year ended December 31, 2022.

Geographical Segmented Informat

Geographical Segmented Information	12 Months Ended
	Dec. 31, 2022
Geographical Segmented Information Disclosure [Abstract]
GEOGRAPHICAL SEGMENTED INFORMATION	17. GEOGRAPHICAL SEGMENTED INFORMATION The Company is engaged in three business activities, the live events business, which includes partnering with multiple professional sports franchises to drive in-stadium audience engagement; a software licensing business creating a recurring revenue stream; and a business-to-business software platform that allows video game publishers and developers to offer prize-based matches of their games to their players. Details of identifiable assets by geographic segments are as follows: Restricted deposits Deposits Goodwill Property and equipment Intangible assets December 31, 2022 Canada $ 8,489 $ - $ - $ - $ - USA - 100,000 - 172,841 7,058,366 $ 8,489 $ 100,000 - $ 172,841 $ 7,058,366 December 31, 2021 Canada $ 9,068 $ - $ - $ - $ - USA - 100,000 6,580,660 326,945 9,172,507 $ 9,068 $ 100,000 6,580,660 $ 326,945 $ 9,172,507

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2022
Supplemental Cash Flow Information [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	18. SUPPLEMENTAL CASH FLOW INFORMATION December 31, December 31, December 31, ($) ($) ($) Non-cash investing and financing activities: Contribution benefit on low interest rate notes - - 170,329 Shares issued to acquire Holdco shares 11,441 - - Shares issued in connection with Xcite acquisition 4,196 - - Common shares issued to settle debt - 107,671 - Deferred financing costs included in accrued expenses - $ 174,813 $ 398,276 Fair value common shares issued in acquisition - $ 13,184,384 -

Lease Obligations and Commitmen

Lease Obligations and Commitments	12 Months Ended
	Dec. 31, 2022
Lease Obligations and Commitments [abstract]
LEASE OBLIGATIONS AND COMMITMENTS	19. LEASE OBLIGATIONS AND COMMITMENTS Lease Liabilities $ Lease liabilities recognized as of January 1, 2021 641,251 Lease payments made (251,383 ) Interest expense on lease liabilities 39,836 Foreign exchange adjustment (61,820 ) Lease liabilities recognized as of January 1, 2022 367,884 Lease payments made (260,184 ) Interest expense on lease liabilities 20,860 128,560 Less: current portion (128,560 ) At December 31, 2022 – non-current portion 0 On August 1, 2015, the Company entered into a cost sharing arrangement agreement for the provision of office space and various administrative services. In May of 2018, the Company extended the cost sharing arrangement to July of 2022 at a monthly fee of CAD $7,000 plus GST per month. On September 6, 2017, the Company entered into a rental agreement for office space in Los Angeles, California. Under the terms of the agreement the Company will pay $17,324 per month commencing on October 1, 2017 until June 30, 2023. Year Amount ($) 2023 131,576

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Taxes [Abstract]
INCOME TAXES	20. INCOME TAXES a) Provision for Income Taxes A reconciliation of income taxes at statutory rates with the reported taxes is as follows: 2022 2021 2020 ($) ($) ($) Loss for the year (21,762,333 ) (17,847,892 ) (6,911,040 ) Expected income tax (recovery) (5,876,000 ) (4,819,000 ) (1,866,000 ) Change in statutory, foreign tax, foreign exchange rates and other (12,000 ) 294,000 275,000 Permanent differences 1,875,000 1,107,000 403,000 Share issue costs 370,000 432,000 - Adjustment to prior years provision versus statutory tax returns - - (35,000 ) Change in unrecognized deductible temporary differences 3,643,000 2,986,000 1,223,000 Income tax expense - - - b) Deferred Income Taxes The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows: 2022 2021 2020 ($) ($) ($) Non-capital losses carry-forward 14,519,000 11,751,000 7,841,000 Exploration and evaluation assets 1,470,000 1,470,000 1,470,000 Share issuance costs 789,000 735,000 109,000 Debt with accretion - (70,000 ) (70,000 ) Intangible assets 622,000 179,000 1,336,000 Other deferreds 12,000 37,000 - Allowable capital losses 3,558,000 3,801,000 3,592,000 Property and equipment 76,000 35,000 64,000 21,046,000 17,938,000 14,342,000 Unrecognized deferred tax assets (21,046,000 ) (17,938,000 ) (14,342,000 ) b) Deferred Income Taxes The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows: Temporary Differences 2022 Expiry Date Range 2021 Expiry Date Range ($) ($) Non-capital losses available for future periods - US 41,188,000 2036 to indefinite 29,390,000 2036 to indefinite Non-capital losses available for future periods - Canada 21,739,000 2026 to 2042 20,664,000 2026 to 2041 Allowable capital losses 13,178,000 No expiry date 14,077,000 No expiry date Property and equipment 270,000 No expiry date 128,000 No expiry date Intangible assets 2,962,000 No expiry date 853,000 No expiry date Exploration and evaluation assets 5,446,000 No expiry date 5,446,000 No expiry date Share issuance costs 2,922,000 No expiry date 2,724,000 No expiry date Tax attributes are subject to review, and potential adjustment, by tax authorities.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events Disclosure [Abstract]
SUBSEQUENT EVENTS	21. SUBSEQUENT EVENTS The Company has evaluated subsequent events after the balance sheet date of December 31, 2022 through March 29, 2023, the date the consolidated financial statements were issued. Based upon its evaluation, management has determined that no subsequent events have occurred that would require recognition in the accompanying consolidated financial statements or disclosure in the notes thereto, except as follows: 1. Subsequent to December 31, 2022, existing holders of the Company’s warrants exercised a combined 4,042,000 warrants at a price of $1.10 per warrant, resulting in $4,446,200 gross cash proceeds for the Company. 2. On February 6, 2023, the Company issued 2,500,000 shares at a price of $0.90 per share in a registered direct offering. The gross proceeds to the Company from this offering are approximately $2,250,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. 3. Subsequent to December 31, 2022, the Company paid CAD$50,000 in notes payable to director Brian Tingle in full satisfaction of a note maturing in January 2023.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basic and diluted loss per share	Basic and diluted loss per share Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common shareholders by the weighted average number of shares outstanding during the reporting periods. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of stock options and warrants, if dilutive. The number of additional shares is calculated by assuming that outstanding stock options and warrants were exercised and that the proceeds from such exercises were used to acquire common stock at the average market price during the reporting periods. Potentially dilutive options and warrants excluded from diluted loss per share as of December 31, 2022, totaled 7,081,173 (December 31, 2021 – 428,527).
Property and Equipment	Property and equipment Property and equipment is recorded at cost less accumulated amortization and any impairments. Amortization is calculated based on the estimated residual value and estimated economic life of the specific assets using the straight-line method over the period indicated below: Asset Rate Computers Straight line, 3 years Right of use assets Shorter of useful life or lease term
Financial instruments	Financial instruments Classification The Company classifies its financial instruments in the following categories: at fair value through profit and loss (FVTPL), at fair value through other comprehensive income (loss) (FVTOCI), or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company’s business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL. Measurement The following table shows the classification of financial instruments: Financial assets/liabilities Classification IFRS 9 Cash FVTPL Receivables Amortized cost Restricted deposit Amortized cost Deposit Amortized cost Accounts payable and accrued liabilities Amortized cost Notes payable Amortized cost Financial assets and liabilities at amortized cost Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment. Financial assets and liabilities at FVTPL Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in profit or loss in the period in which they arise. Impairment of financial assets at amortized cost An ‘expected credit loss’ impairment model applies which requires a loss allowance to be recognized based on expected credit losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present value of the future cash flows associated with the asset, discounted at the financial asset’s original effective interest rate, either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period. In a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the impairment reversed does not exceed what the amortized cost would have been had the impairment not been recognized.
Intangible assets excluding goodwill	Intangible assets excluding goodwill Derecognition of financial assets The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition are generally recognized in profit or loss. As at December 31, 2022, the Company does not have any derivative financial assets and liabilities. Intangible assets acquired separately are carried at cost at the time of initial recognition. Intangible assets acquired in a business combination and recognized separately from goodwill are initially recognized at their fair value at the acquisition date. Expenditure on research activities is recognized as an expense in the period in which it is incurred. Intangibles with a finite useful life are amortized and those with an indefinite useful life are not amortized. The useful life is the best estimate of the period over which the asset is expected to contribute directly or indirectly to the future cash flows of the Company. The useful life is based on the duration of the expected use of the asset by the Company and the legal, regulatory or contractual provisions that constrain the useful life and future cash flows of the asset, including regulatory acceptance and approval, obsolescence, demand, competition and other economic factors. If an income approach is used to measure the fair value of an intangible asset, the Company considers the period of expected cash flows used to measure the fair value of the intangible asset, adjusted as appropriate for Company-specific factors discussed above, to determine the useful life for amortization purposes. If no regulatory, contractual, competitive, economic or other factors limit the useful life of the intangible to the Company, the useful life is considered indefinite. Intangibles with a finite useful life are amortized on the straight-line method unless the pattern in which the economic benefits of the intangible asset are consumed or used up are reliably determinable. The Company evaluates the remaining useful life of intangible assets each reporting period to determine whether any revision to the remaining useful life is required. If the remaining useful life is changed, the remaining carrying amount of the intangible asset will be amortized prospectively over the revised remaining useful life. The Company’s intangible asset is amortized on a straight-line basis over 3 years. In the year development costs are incurred, amortization is based on a half year.
Goodwill	Goodwill The Company allocates goodwill arising from business combinations to each cash generating unit (CGU) or group of CGUs that are expected to receive the benefits from the business combination. The carrying amount of the CGU or group of CGUs to which goodwill has been allocated is tested annually for impairment or when there is an indication that the goodwill may be impaired. Any impairment is recognized as an expense immediately. Should there be a recovery in the value of a CGU, any impairment of goodwill previously recorded is not subsequently reversed.
Deferred Financing Costs	Deferred financing costs Deferred financing costs consist primarily of direct incremental costs related to the Company’s public offering of its common stock completed in February 2022. Upon completion of the Company’s financing any deferred costs were offset against the proceeds. The Company incurred $174,813 during the year ended December 31, 2021, and $0 during the year ended December 31, 2022.
Impairment of intangible assets excluding goodwill	Impairment of intangible assets excluding goodwill An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognized if, and only if, all of the following have been demonstrated: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) the intention to complete the intangible asset and use or sell it; (c) the ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) the ability to measure reliably the expenditure attributable to the intangible asset during its development. The amount initially recognized for internally-generated intangible assets is the sum of the costs incurred from the date when the intangible assets first meet the recognition criteria listed above. If no future economic benefit is expected before the end of the life of assets, the residual book value is expensed. Subsequent to initial recognition, internally-generated intangible assets are reported at cost. Where no internally-generated intangible asset can be recognized, development costs are recognized as an expense in the period in which it is incurred. At the end of each reporting period, the Company reviews the carrying amounts of its intangible assets to determine whether there is any indication that those assets have suffered impairment losses. If any such indication exists, the recoverable amount of the cash-generating unit (CGU) to which the asset belongs is estimated in order to determine the extent of the impairment losses (if any). Where a reasonable and consistent basis of allocation can be identified, corporate assets (assets other than goodwill that contribute to the future cash flows of both the CGU under review and other CGUs) are also allocated to individual CGUs, or otherwise they are allocated to the smallest group of CGUs for which a reasonable and consistent allocation basis can be identified. Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or CGU) is estimated to be less than its carrying amount, the carrying amount of the asset (or CGU) is reduced to its recoverable amount. Where impairment losses subsequently reverse, the carrying amount of the asset (or CGU) is increased to the revised estimate of its recoverable amount, such that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment losses been recognized for the asset (or CGU) in prior years. A reversal of impairment losses is recognized immediately in profit or loss.
Income taxes	Income taxes Tax expense recognized in profit or loss comprises the sum of current tax and deferred tax not recognized in other comprehensive income or directly in equity.
Current Income Tax	Current income tax Current income tax assets and/or liabilities comprise those claims from, or obligations to, fiscal authorities relating to the current or prior reporting periods that are unpaid at the reporting date. Current tax is payable on taxable profit, which differs from profit or loss in the consolidated financial statements. Calculation of current tax is based on tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period.
Deferred income tax	Deferred income tax Deferred income taxes are calculated based on temporary differences between the carrying amounts of assets and liabilities and their tax bases. Deferred tax assets and liabilities are calculated, without discounting, at tax rates that are expected to apply to their respective period of realization, provided they are enacted or substantively enacted by the end of the reporting period. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income. Deferred tax assets and liabilities are offset only when the Company has a right and intention to offset current tax assets and liabilities from the same taxation authority. Changes in deferred tax assets or liabilities are recognized as a component of tax income or expense in profit or loss, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively.
Leases	Leases Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the Company. Assets and liabilities arising from a lease are initially measured on a present value basis. Right-of-use assets are measured at cost comprising the following: - the amount of the initial measurement of lease liability; - any lease payments made at or before the commencement date less any lease incentives received; - any initial direct costs; and - restoration costs. The Company assesses whether a contract is or contains a lease, at inception of a contract. The Company recognizes a right-of-use asset and a corresponding lease liability with respect to all lease agreements in which it is the lessee. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the Company uses its incremental borrowing rate. Lease liability The lease liability is subsequently measured by increasing its carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect lease payments made. The right-of-use asset is depreciated over the shorter of the lease term and the useful life of the underlying asset. The Company applies IAS 36, Impairment of Assets, to determine whether the asset is impaired and account for any identified impairment loss. As a practical expedient, IFRS 16 permits a lease not to separate non-lease components, and instead account for any lease and associated non-lease components as a single arrangement. The Company has not used this practical expedient, and accordingly allocates the consideration in the contract to lease and non-lease components based on the stand-alone price of the lease component and aggregate stand-alone price of the non-lease components. Variable rents that do not depend on an index or rate are not included in the measurement of the lease liability and the right-of-use asset. The related payments are recognized as an expense in the period in which the event or condition that triggers those payments occurs and are presented as such in the statements of income and comprehensive income.
Provisions	Provisions A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability.
Government grant	Government grants Government grants are recognized when there is reasonable assurance that the Company will comply with any conditions attached to the grant and the grant will be received. Government grants are recognized in profit or loss to offset the corresponding expenses on a systematic basis over the periods in which the Company recognizes expenses for the related costs for which the grants are intended to compensate, which in the case of grants related to assets requires setting up the grant as deferred income or deducting it from the carrying amount of the asset.
Non-controlling interest	Non-controlling interest Non-controlling interest in the Company’s less than wholly owned subsidiary is classified as a separate component of equity. On initial recognition, non-controlling interest is measured at the fair value of the non-controlling entity’s contribution into the related subsidiary. Subsequent to the original transaction date, adjustments are made to the carrying amount of non-controlling interest for the non-controlling interest’s share of changes to the subsidiary’s equity. Changes in the Company’s ownership interest in a subsidiary that do not result in a loss of control are recorded as equity transactions. The carrying amount of non-controlling interest is adjusted to reflect the change in the non-controlling interest’s relative interest in the subsidiary, and the difference between the adjustment to the carrying amount of non-controlling interests and the Company’s share of proceeds received and/or consideration paid is recognized directly in equity and attributed to owners of the Company.
Valuation of equity units issued in private placements	Valuation of equity units issued in private placements The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in private placements is determined to be the more easily measurable component and are valued at their fair value. The balance, if any, is allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in the warrant reserve.
Warrants issued in equity financing transactions	Warrants issued in equity financing transactions The Company engages in equity financing transactions to obtain funds necessary to continue operations. These equity financing transactions may involve issuance of common shares or units. Each unit comprises a certain number of shares and a certain number of warrants. Depending on the terms and conditions of each equity financing transaction, the warrants are exercisable into additional common shares at a price prior to expiry as stipulated by the transaction. Warrants that are part of units are assigned a value based on the residual value, if any, and included in reserves. As of February 1, 2021, the warrants were considered a derivative liability since the obligation to issue shares was not fixed in the Company’s functional currency. The derivative warrant liability was measured as fair value at issue with subsequent changes recognized in the consolidated statement of loss and comprehensive loss. A $9,743,659 warrant derivative loss was recorded in the consolidated statement of loss and comprehensive loss beginning February 1, 2021 when the Company changed its functional currency. As of December 31, 2022 the associated warrants have expired and the remaining balance of the warrant liability is $0. The Company uses the Black-Scholes Option Pricing Model for valuation of share-based payments and derivative financial assets (e.g. investments in warrants). Option pricing models require the input of subjective assumptions including expected price volatility, interest rates, and forfeiture rates. Changes in the input assumptions can materially affect the fair value estimate and the Company’s earnings and equity reserves.
Share-based Compensation	Share-based compensation The Company grants stock options to acquire common shares of the Company to directors, officers, employees and consultants. An individual is classified as an employee when the individual is an employee for legal or tax purposes, or provides services similar to those performed by an employee. The fair value of stock options is measured on the date of grant, using the Black-Scholes option pricing model, and is recognized over the vesting period. Consideration paid for the shares on the exercise of stock options is credited to capital stock. In situations where equity instruments are issued to non-employees and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.
Revenue recognition	Revenue recognition In general, the Company recognizes revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the Company, where there is evidence of an arrangement, when the selling price is fixed or determinable, and when specific criteria have been met or there are no significant remaining performance obligations for each of the Company’s activities as described below. Foreseeable losses, if any, are recognized in the year or period in which the loss is determined. The Company earns revenue in three primary ways: 1) the sales of software-as-a-service (SAAS) from its interactive production software platform, 2) development and maintenance of custom-built software or other professional services, or 3) the sale of advertising. The Company recognizes SAAS revenues from its interactive production sales over the life of the contract as its performance obligations are satisfied. Payment terms vary by contract and can be periodic or one-time payments. The Company recognizes revenues received from the development and maintenance of custom-built software and other professional services provided upon the satisfaction of its performance obligation in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. Performance obligations can be satisfied either at a single point in time or over time. For those performance obligations that are satisfied at a single point in time, the revenue is recognized at that time. For each performance obligation satisfied over time, the Company recognizes revenue by measuring the progress toward complete satisfaction of that performance obligation. For revenues received from the sales of advertising, the Company is deemed the agent in its revenue agreements. The Company does not own or obtain control of the digital advertising inventory. The Company recognizes revenues upon the achievement of agreed-upon performance criteria for the advertising inventory, such as a number of views, or clicks. As the Company is acting as an agent in the transaction, the Company recognizes revenue from sales of advertising on a net basis, which excludes amounts payable to partners under the Company’s revenue sharing agreements. The Company’s contracts with customers may include promises to transfer multiple products and services. For these contracts, the Company accounts for individual performance obligations separately if they are capable of being distinct and distinct within the context of the contract. Determining whether products and services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the stand-alone selling price, for each distinct performance obligation. As the Company’s performance obligations are satisfied within 12 months, the Company has elected the practical expedients under IFRS 15, which allows the Company not to record any significant financing component as a result of financing any of its arrangements and not to capitalize cost incurred to obtain a contract.
Deferred Revenue	Deferred revenue Revenue recognition of sales is recorded on a monthly basis upon delivery or as the services are provided. Cash received in advance for services are recorded as deferred revenue based on the proportion of time remaining under the service arrangement as of the reporting date.
Foreign Exchange	Foreign exchange The functional currency is the currency of the primary economic environment in which the entity operates and has been determined for each entity within the Company. The functional currency for the Company and its subsidiaries is the United States dollar. The functional currency determinations were conducted through an analysis of the consideration factors identified in IAS 21, The Effects of Changes in Foreign Exchange Rates. Foreign currency transactions in currencies other than the United States dollar are recorded at exchange rates prevailing on the dates of the transactions. Foreign currency transaction gains and losses are generally recognized in profit or loss and presented within gain (loss) on foreign exchange. At the end of each reporting period, the monetary assets and liabilities of the Company and its subsidiaries that are denominated in foreign currencies are translated at the rate of exchange at the date of the statement of financial position. Non-monetary assets and liabilities that are denominated in foreign currencies are translated at historical rates. Revenues and expenses that are denominated in foreign currencies are translated at the exchange rates approximating those in effect on the date of the transactions. Foreign currency translation gains and losses are recognized in other comprehensive income and accumulated in equity within the currency translation reserve.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive income (loss) consists of net income (loss) and other comprehensive income (loss) and represents the change in shareholders’ equity (deficit) which results from transactions and events from sources other than the Company’s shareholders. Comprehensive loss differs from net loss for the year ended December 31, 2022 due to the effects of foreign translation gains and losses. Net loss is the same as comprehensive loss for the year ended December 31, 2021. Net loss differs from comprehensive loss for the year ending December 31, 2020 as a result of the change in presentation and functional currency.

Basis of Presentation (Tables)

Basis of Presentation (Tables)	12 Months Ended
	Dec. 31, 2022
Basis of Presentation [abstract]
Schedule of subsidiary	Name of Subsidiary Place of Incorporation Proportion of Principal Activity Versus Systems (Holdco) Inc. United States of America 81.9 % Holding Company Versus Systems UK, Ltd. United Kingdom 81.9 % Sales Company Versus LLC United States of America 81.9 % Technology Company Xcite Interactive, Inc. United States of America 100.0 % Technology Company

Significant Accounting Polici_2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Significant Accounting Policies [abstract]
Schedule of estimated residual value and estimated economic life of the specific assets	Asset Rate Computers Straight line, 3 years Right of use assets Shorter of useful life or lease term
Schedule of financial assets and liabilities	Financial assets/liabilities Classification IFRS 9 Cash FVTPL Receivables Amortized cost Restricted deposit Amortized cost Deposit Amortized cost Accounts payable and accrued liabilities Amortized cost Notes payable Amortized cost

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2022
Property and Equipment [Abstract]
Schedule of property and equipment	Computers Right of Use Asset Total ($) ($) ($) Cost At December 31, 2020 88,329 936,958 1,025,287 Additions 108,974 - 108,974 Foreign currency adjustment (15,913 ) (23,553 ) (39,466 ) At December 31, 2021 181,390 913,405 1,094,795 Additions 65,329 - 65,329 At December 31, 2022 246,719 913,405 1,160,124 Accumulated amortization At December 31, 2020 82,286 449,191 531,477 Amortization for the year 30,793 205,580 236,373 At December 31, 2021 113,079 654,771 767,850 Amortization for the period 39,667 179,766 219,433 At December 31, 2022 152,746 834,537 987,283 Carrying amounts At December 31, 2020 6,044 475,817 481,861 At December 31, 2021 68,311 258,634 326,945 At December 31, 2022 93,973 78,868 172,841

Non-Controlling Interest in V_2

Non-Controlling Interest in Versus LLC (Tables)	12 Months Ended
	Dec. 31, 2022
Non-Controlling Interest in Versus LLC [Abstract]
Schedule of financial information before intragroup eliminations for non-wholly owned subsidiary	2022 2021 2020 Non-controlling interest percentage 18.1% 33.2% 33.2% ($) ($) ($) Assets Current 1,011,636 1,488,892 779,123 Non-current 2,910,990 2,300,268 2,289,645 3,922,626 3,789,160 3,068,768 Liabilities Current 518,701 763,970 1,020,192 Non-current 39,774,321 30,661,143 17,329,272 40,293,022 31,425,113 18,349,464 Net liabilities (36,370,396 ) (27,635,953 ) (15,280,696 ) Non-controlling interest (6,383,129 ) (8,621,581 ) (5,193,701 ) Net loss (10,090,734 ) (17,847,892 ) (6,911,040 ) Net loss attributed to non-controlling interest (2,137,885 ) (3,448,820 ) (1,464,660 )

Acquisition of Xcite Interact_2

Acquisition of Xcite Interactive, Inc. (Tables)	12 Months Ended
	Dec. 31, 2022
Acquisition of Xcite Interactive, Inc. [abstract]
Schedule of consideration	Common shares $ 12,890,029 Cash 112,225 Working capital adjustment (163,902 ) PPP shares 346,031 Total Consideration $ 13,184,383 Identifiable Assets Acquired and Liabilities Assumed Cash $ 27,124 Accounts Receivable 37,719 Property, Plant and Equipment 34,496 Intangible Assets 7,140,000 Other Assets 12,409 Accounts Payable and Accrued Liabilities (524,853 ) Other Liabilities (123,171 ) Total Identifiable Assets $ 6,603,724 Goodwill $ 6,580,659

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Intangible Assets [Abstract]
Schedule of intangible assets	Software Customer Relationships Tradename Developed Technology Total Cost At December 31, 2020 9,914,104 - - - 9,914,104 Foreign currency adjustment (47,444 ) (47,444 ) Additions 2,352,248 4,840,000 750,000 1,550,000 9,492,248 At December 31, 2021 12,218,908 4,840,000 750,000 1,550,000 19,358,908 Additions 2,496,621 - - - 2,496,621 Impairments - (1,194,377 ) (235,555 ) (243,407 ) (1,673,340 ) At December 31, 2022 14,748,072 3,645,623 514,445 1,306,593 20,214,732 Accumulated amortization At December 31, 2020 8,176,688 - - - 8,176,688 Amortization 1,304,991 403,333 - 301,389 2,009,713 At December 31, 2021 9,481,679 403,333 - 301,389 10,186,401 Amortization 1,729,326 691,430 - 516,667 2,937,423 At December 31, 2022 11,334,223 1,037,144 - 775,000 13,156,368 Carrying amounts At December 31, 2020 2,256,903 - - - 1,737,416 At December 31, 2021 2,636,555 4,494,286 750,000 1,291,667 9,172,507 At December 31, 2022 3,403,849 2,608,479 514,445 531,593 7,058,366

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Accounts Payable and Accrued Liabilities [abstract]
Schedule accounts payable and accrued liabilities	December 31, 2022 December 31, ($) ($) Accounts payable (Note 12) 138,276 386,030 Due to related parties (Note 12 and Note 14) 304,623 302,883 Accrued liabilities (Note 12) 79,113 143,486 522,012 832,399

Notes Payable _ Related Party (

Notes Payable – Related Party (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Payable – Related Party [Abstract]
Schedule of notes to their present value	Amount ($) Balance at December 31, 2020 4,528,549 Proceeds - Repayments (2,058,720 ) Contribution benefit - Finance expense 225,196 Foreign exchange adjustment 91,158 Balance, December 31, 2021 2,786,183 Foreign currency adjustment (177,690 ) Repayments (64,550 ) Finance expense 60,770 Balance, December 31, 2022 2,604,713 Current 2,604,713 Non-current 0

Share Capital and Reserves (Tab

Share Capital and Reserves (Tables)	12 Months Ended
	Dec. 31, 2022
Share Capital and Reserves [abstract]
Schedule of outstanding stock options	Number Outstanding Weighted Average Exercise Price ($) Balance – December 31, 2020 90,255 55.50 Granted 64,015 73.05 Exercised (7,869 ) 49.80 Forfeited (16,950 ) 50.85 Balance –December 31, 2021 129,451 63.60 Granted 104,520 6.19 Exercised - - Forfeited (6,183 ) 92.81 Balance – December 31, 2022 227,788 37.13
Schedule of fair value of stock options	December 31, December 31, Risk-free interest rate 2.14% – 4.03% 0.04% - 0.47% Expected life of options 5.0 years 5.0 years Expected dividend yield Nil Nil Volatility 96.90% – 112.40% 102% - 128%
Schedule of incentive stock options outstanding	Expiry Date Options Outstanding Exercise Price Weighted Average ($) (years) June 6, 2023 937 85.50 0.93 September 4, 2023 855 44.55 1.18 April 2, 2024 7,129 37.80 1.76 June 27, 2024 417 38.40 1.99 September 27, 2024 20,005 67.95 2.24 October 22, 2024 834 60.45 2.31 July 24, 2025 16,139 44.70 3.07 July 31, 2025 11,080 44.70 3.07 August 10, 2025 833 44.70 3.11 November 19, 2025 1,024 68.85 2.39 June 1, 2026 3,788 105.60 3.97 June 29, 2026 21,967 84.75 3.97 August 19, 2026 38,260 63.00 3.20 March 18, 2027 1,500 19.80 4.00 May 10, 2027 800 11.85 4.00 August 17, 2027 99,980 6.00 4.80 September 20, 2027 2,240 3.45 4.80 227,788 37.13 3.82
Schedule of outstanding share purchase warrants	Number Outstanding Weighted Average Exercise Price ($) Balance – December 31, 2020 179,508 54.15 Exercised (72,581 ) 63.15 Expired (32,830 ) 63.15 Issued 224,979 112.50 Balance – December 31, 2021 299,077 102.45 Exercised - - Expired (186,586 ) 96.30 Issued 5,166,044 3.42 Balance – December 31, 2022 (1) 5,278,535 5.74
Schedule of assumptions in calculating the fair value of the warrants	December 31, December 31, Risk-free interest rate 3.99% - 4.22% 0.25 % Expected life of warrants 3.06 – 5.05 years 0.7 - 1.76 years Expected dividend yield Nil Nil Volatility 119% – 124.9% 75 % Weighted average fair value per warrant $ 0.26 $ 3.38
Schedule of share purchase warrants outstanding	Expiry Date Warrants Outstanding Exercise Price Weighted Average Remaining Life ($) (years) January 20, 2026 (1) 112,491 112.50 3.06 February 28, 2027 331,044 28.80 4.16 December 6, 2027 220,500 1.25 4.93 December 9, 2027 4,200,000 1.10 4.94 January 18, 2028 414,500 7.80 5.05 5,278,535 5.74 4.45

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Schedule of key management personnel	Key Management Personnel 2022 2021 ($) ($) Short-term employee benefits paid or accrued to the CEO of the Company, including share-based compensation vested for incentive stock options and performance warrants. 350,657 335,430 Short-term employee benefits paid or accrued to the CFO of the Company, including share-based compensation vested for incentive stock options and performance warrants. 363,291 447,710 Short-term employee benefits paid or accrued to a member of the advisory board of the Company, including share-based compensation vested for incentive stock options and performance warrants. 215,038 215,706 Short-term employee benefits paid or accrued to the Chief Technology Officer of the Company, including share-based compensation vested for incentive stock options and performance warrants. 306,441 289,290 Short-term employee benefits paid or accrued to a Director of the Company, including share-based compensation vested for incentive stock options and performance warrants. 293,585 - Short-term employee benefits paid or accrued to the Chief People Officer of the Company, including share-based compensation vested for incentive stock options and performance warrants. 205,681 - Short-term employee benefits paid or accrued to other directors and officers of the Company, including share-based compensation vested for incentive stock options and performance warrants. 426,153 666,586 Total 2,160,846 1,954,722

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	12 Months Ended
	Dec. 31, 2022
Financial Instruments and Risk Management [Abstract]
Schedule of foreign currency risk	December 31, 2022 December 31, 2021 ($) ($) Cash 245,858 162,135 Accounts payable and accrued liabilities (93,630 ) (142,726 ) 152,228 19,409

Geographical Segmented Inform_2

Geographical Segmented Information (Tables)	12 Months Ended
	Dec. 31, 2022
Geographical Segmented Information [Abstract]
Schedule of identifiable assets by geographic segments	Restricted deposits Deposits Goodwill Property and equipment Intangible assets December 31, 2022 Canada $ 8,489 $ - $ - $ - $ - USA - 100,000 - 172,841 7,058,366 $ 8,489 $ 100,000 - $ 172,841 $ 7,058,366 December 31, 2021 Canada $ 9,068 $ - $ - $ - $ - USA - 100,000 6,580,660 326,945 9,172,507 $ 9,068 $ 100,000 6,580,660 $ 326,945 $ 9,172,507

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2022
Supplemental Cash Flow Information [Abstract]
Schedule of supplemental cash flow Information	December 31, December 31, December 31, ($) ($) ($) Non-cash investing and financing activities: Contribution benefit on low interest rate notes - - 170,329 Shares issued to acquire Holdco shares 11,441 - - Shares issued in connection with Xcite acquisition 4,196 - - Common shares issued to settle debt - 107,671 - Deferred financing costs included in accrued expenses - $ 174,813 $ 398,276 Fair value common shares issued in acquisition - $ 13,184,384 -

Lease Obligations and Commitm_2

Lease Obligations and Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Lease Obligations and Commitments [abstract]
Schedule of lease liabilities	$ Lease liabilities recognized as of January 1, 2021 641,251 Lease payments made (251,383 ) Interest expense on lease liabilities 39,836 Foreign exchange adjustment (61,820 ) Lease liabilities recognized as of January 1, 2022 367,884 Lease payments made (260,184 ) Interest expense on lease liabilities 20,860 128,560 Less: current portion (128,560 ) At December 31, 2022 – non-current portion 0
Schedule of rental agreement for office space	Year Amount ($) 2023 131,576

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Taxes [Abstract]
Schedule of income taxes at statutory rates	2022 2021 2020 ($) ($) ($) Loss for the year (21,762,333 ) (17,847,892 ) (6,911,040 ) Expected income tax (recovery) (5,876,000 ) (4,819,000 ) (1,866,000 ) Change in statutory, foreign tax, foreign exchange rates and other (12,000 ) 294,000 275,000 Permanent differences 1,875,000 1,107,000 403,000 Share issue costs 370,000 432,000 - Adjustment to prior years provision versus statutory tax returns - - (35,000 ) Change in unrecognized deductible temporary differences 3,643,000 2,986,000 1,223,000 Income tax expense - - -
Schedule of deferred income taxes	2022 2021 2020 ($) ($) ($) Non-capital losses carry-forward 14,519,000 11,751,000 7,841,000 Exploration and evaluation assets 1,470,000 1,470,000 1,470,000 Share issuance costs 789,000 735,000 109,000 Debt with accretion - (70,000 ) (70,000 ) Intangible assets 622,000 179,000 1,336,000 Other deferreds 12,000 37,000 - Allowable capital losses 3,558,000 3,801,000 3,592,000 Property and equipment 76,000 35,000 64,000 21,046,000 17,938,000 14,342,000 Unrecognized deferred tax assets (21,046,000 ) (17,938,000 ) (14,342,000 )
Schedule of deferred income taxes unused tax credits and unused tax losses	Temporary Differences 2022 Expiry Date Range 2021 Expiry Date Range ($) ($) Non-capital losses available for future periods - US 41,188,000 2036 to indefinite 29,390,000 2036 to indefinite Non-capital losses available for future periods - Canada 21,739,000 2026 to 2042 20,664,000 2026 to 2041 Allowable capital losses 13,178,000 No expiry date 14,077,000 No expiry date Property and equipment 270,000 No expiry date 128,000 No expiry date Intangible assets 2,962,000 No expiry date 853,000 No expiry date Exploration and evaluation assets 5,446,000 No expiry date 5,446,000 No expiry date Share issuance costs 2,922,000 No expiry date 2,724,000 No expiry date

Basis of Presentation (Details)

Basis of Presentation (Details) - Schedule of subsidiary	12 Months Ended
	Dec. 31, 2022
Versus Systems (Holdco) Inc. [Member]
Basis of Presentation (Details) - Schedule of subsidiary [Line Items]
Name of Subsidiary	Versus Systems (Holdco) Inc.
Place of Incorporation	United States of America
Proportion of Ownership Interest	81.90%
Principal Activity	Holding Company
Versus Systems UK, Ltd. [Member]
Basis of Presentation (Details) - Schedule of subsidiary [Line Items]
Name of Subsidiary	Versus Systems UK, Ltd.
Place of Incorporation	United Kingdom
Proportion of Ownership Interest	81.90%
Principal Activity	Sales Company
Versus LLC [Member]
Basis of Presentation (Details) - Schedule of subsidiary [Line Items]
Name of Subsidiary	Versus LLC
Place of Incorporation	United States of America
Proportion of Ownership Interest	81.90%
Principal Activity	Technology Company
Xcite Interactive, Inc. [Member]
Basis of Presentation (Details) - Schedule of subsidiary [Line Items]
Name of Subsidiary	Xcite Interactive, Inc.
Place of Incorporation	United States of America
Proportion of Ownership Interest	100%
Principal Activity	Technology Company

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($)		12 Months Ended
	Feb. 01, 2021	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Significant Accounting Policies Text Block Abstract
Loss per share totalled		$ 7,081,173	$ 428,527
Intangible assets useful life		3 years
Deferred tax asset		$ 0	$ 174,813
Warrant derivative loss	$ 9,743,659
Warrant liability		$ 0

Significant Accounting Polici_4

Significant Accounting Policies (Details) - Schedule of estimated residual value and estimated economic life of the specific assets	12 Months Ended
	Dec. 31, 2022
Computers [Member]
Significant Accounting Policies (Details) - Schedule of estimated residual value and estimated economic life of the specific assets [Line Items]
Description of useful life	Straight line, 3 years
Right of use assets [Member]
Significant Accounting Policies (Details) - Schedule of estimated residual value and estimated economic life of the specific assets [Line Items]
Description of useful life	Shorter of useful life or lease term

Significant Accounting Polici_5

Significant Accounting Policies (Details) - Schedule of financial assets and liabilities	12 Months Ended
	Dec. 31, 2022
Schedule Of Financial Assets And Liabilities Abstract
Cash	FVTPL
Receivables	Amortized cost
Restricted deposit	Amortized cost
Deposit	Amortized cost
Accounts payable and accrued liabilities	Amortized cost
Notes payable	Amortized cost

Change in Functional and Pres_2

Change in Functional and Presentation Currency (Details)	12 Months Ended
	Dec. 31, 2022
Change In Functional And Presentation Currency Abstract
Functional and presentation currency description	All assets and liabilities previously reported in Canadian dollars have been translated into United States dollars as at February 1, 2021 using the period-end noon exchange rates of 0.782 CAD/USD. As a practical measure, the comparative shareholders’ equity (deficit) balances were translated at the February 1, 2021 exchange rate of 1.2824 CAD/USD. All resulting translation exchange differences have been recognized within other comprehensive income in the foreign currency translation reserve.

Receivables (Details)

Receivables (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Receivables (Details) [Line Items]
Customer receivables	$ 46,592
Accounts receivable	$ 6,100
Allowance for doubtful accounts description	As of December 31, 2021, accounts receivable consists of customer receivables of $90,808 (net an allowance for doubtful accounts of $11,500) and GST receivable of $32,809.
GST [Member]
Receivables (Details) [Line Items]
Accounts receivable	$ 14,157

Restricted Deposit (Details)

Restricted Deposit (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Restricted Deposit Abstract
Guaranteed investment	$ 8,489	$ 9,068

Property and Equipment (Details

Property and Equipment (Details) - Schedule of property and equipment - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cost
Cost Balance at beginning	$ 1,094,795	$ 1,025,287
Cost Balance at Ending	1,160,124	1,094,795
Additions	65,329	108,974
Foreign currency adjustment		(39,466)
Accumulated amortization
Accumulated amortization, Balance at beginning	767,850	531,477
Accumulated amortization, Balance at Ending	987,283	767,850
Amortization for the year	219,433	236,373
Carrying amounts
Carrying amounts	172,841	326,945	$ 481,861
Computers [Member]
Cost
Cost Balance at beginning	181,390	88,329
Cost Balance at Ending	246,719	181,390
Additions	65,329	108,974
Foreign currency adjustment		(15,913)
Accumulated amortization
Accumulated amortization, Balance at beginning	113,079	82,286
Accumulated amortization, Balance at Ending	152,746	113,079
Amortization for the year	39,667	30,793
Carrying amounts
Carrying amounts	93,973	68,311	6,044
Right of Use Asset [Member]
Cost
Cost Balance at beginning	913,405	936,958
Cost Balance at Ending	913,405	913,405
Additions
Foreign currency adjustment		(23,553)
Accumulated amortization
Accumulated amortization, Balance at beginning	654,771	449,191
Accumulated amortization, Balance at Ending	834,537	654,771
Amortization for the year	179,766	205,580
Carrying amounts
Carrying amounts	$ 78,868	$ 258,634	$ 475,817

Non-Controlling Interest in V_3

Non-Controlling Interest in Versus LLC (Details) - shares		1 Months Ended
	Mar. 01, 2022	Jun. 21, 2019	May 21, 2019	Dec. 31, 2018
Versus LLC [Member]
Non-Controlling Interest in Versus LLC (Details) [Line Items]
Ownership interest percentage	15.10%	0.30%	25.20%	41.30%
Exchange of common shares	11,441	189	38,268
Purchase of warrants, shares		95	19,134
Opal Energy [Member]
Non-Controlling Interest in Versus LLC (Details) [Line Items]
Business combination, description	The common shares were determined to have a fair value of $186,294. As a result, the Company increased its ownership interest to 81.9% and recorded the excess purchase price over net identifiable assets of $4,562,631 against reserves. The effect on non-controlling interest was a reduction of $4,376,337.	The common shares and the share purchase warrants were determined to have a fair value of $6,906 and $2,527, respectively. As a result, the Company increased its ownership interest to 66.8% and recorded the excess purchase price over net identifiable assets of $26,448 against reserves. The effect on non-controlling interest was a reduction of $19,433.	The common shares and the share purchase warrants were determined to have a fair value of $1,403,675 and $116,595, respectively. As a result, the Company increased its ownership interest to 66.5% and recorded the excess purchase price over net identifiable liabilities of $3,575,884 against reserves. The effect on non-controlling interest was a reduction of $2,053,199.

Non-Controlling Interest in V_4

Non-Controlling Interest in Versus LLC (Details) - Schedule of financial information before intragroup eliminations for non-wholly owned subsidiary - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Financial Information Before Intragroup Eliminations For Non Wholly Owned Subsidiary Abstract
Non-controlling interest percentage	18.10%	33.20%	33.20%
Assets
Current	$ 1,011,636	$ 1,488,892	$ 779,123
Non-current	2,910,990	2,300,268	2,289,645
Total Assets	3,922,626	3,789,160	3,068,768
Liabilities
Current	518,701	763,970	1,020,192
Non-current	39,774,321	30,661,143	17,329,272
Total Liabilities	40,293,022	31,425,113	18,349,464
Net liabilities	(36,370,396)	(27,635,953)	(15,280,696)
Non-controlling interest	(6,383,129)	(8,621,581)	(5,193,701)
Net loss	(10,090,734)	(17,847,892)	(6,911,040)
Net loss attributed to non-controlling interest	$ (2,137,885)	$ (3,448,820)	$ (1,464,660)

Acquisition of Xcite Interact_3

Acquisition of Xcite Interactive, Inc. (Details) - USD ($)		12 Months Ended
	Jun. 03, 2021	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Deferred Acquisition Costs Arising From Insurance Contracts Text Block Abstract
Summary of acquisition description	On June 3, 2021, the Company closed its acquisition of all the issued and outstanding common shares of Xcite Interactive Inc. (Xcite) in exchange for common shares of the Company. Pursuant to the terms of the acquisition, the Company acquired all the issued and outstanding Xcite common shares in consideration for the issuance of 0.0234 of a common shares of the Company for each Xcite common share. The Company issued a total of 100,461 common shares with a fair value of $10.7 million, based on the June 3, 2021 closing share price of $101.40. The Company issued an additional 2,917 shares on July 26, 2021, related to the Payment Protection Program (PPP) loan escrow account that was included in the Xcite debt at the time of the acquisition. In addition, $109,360 of cash was awarded to non-accredited investors of Xcite on June 3, 2021, and additional $2,865 on July 26, 2021.
Recoverable amount		$ 4,425,000
Impairment charges		8,254,000
Goodwill balance		6,580,660
Written down		0	$ 6,580,660
Intangible assets related		1,673,340
Contributed revenues		$ 988,436

Acquisition of Xcite Interact_4

Acquisition of Xcite Interactive, Inc. (Details) - Schedule of consideration	12 Months Ended
	Dec. 31, 2022 USD ($) shares
Schedule Of Consideration Abstract
Common shares (in Shares) | shares	12,890,029
Cash	$ 112,225
Working capital adjustment	(163,902)
PPP shares	346,031
Total Consideration	13,184,383
Identifiable Assets Acquired and Liabilities Assumed
Cash	27,124
Accounts Receivable	37,719
Property, Plant and Equipment	34,496
Intangible Assets	7,140,000
Other Assets	12,409
Accounts Payable and Accrued Liabilities	(524,853)
Other Liabilities	(123,171)
Total Identifiable Assets	6,603,724
Goodwill	$ 6,580,659

Intangible Assets (Details) - S

Intangible Assets (Details) - Schedule of intangible assets - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cost
Balance at Beginning	$ 19,358,908	$ 9,914,104
Foreign currency adjustment		(47,444)
Additions	2,496,621	9,492,248
Impairments	(1,673,340)
Balance at Ending	20,214,732	19,358,908
Accumulated amortization
Balance at Beginning	10,186,401	8,176,688
Amortization	2,937,423	2,009,713
Balance at Ending	13,156,368	10,186,401
Carrying amounts
Balance	7,058,366	9,172,507	$ 1,737,416
Software [Member]
Cost
Balance at Beginning	12,218,908	9,914,104
Foreign currency adjustment		(47,444)
Additions	2,496,621	2,352,248
Impairments
Balance at Ending	14,748,072	12,218,908
Accumulated amortization
Balance at Beginning	9,481,679	8,176,688
Amortization	1,729,326	1,304,991
Balance at Ending	11,334,223	9,481,679
Carrying amounts
Balance	3,403,849	2,636,555	2,256,903
Customer Relationships [Member]
Cost
Balance at Beginning	4,840,000
Additions		4,840,000
Impairments	(1,194,377)
Balance at Ending	3,645,623	4,840,000
Accumulated amortization
Balance at Beginning	403,333
Amortization	691,430	403,333
Balance at Ending	1,037,144	403,333
Carrying amounts
Balance	2,608,479	4,494,286
Tradename [Member]
Cost
Balance at Beginning	750,000
Additions		750,000
Impairments	(235,555)
Balance at Ending	514,445	750,000
Accumulated amortization
Balance at Beginning
Amortization
Balance at Ending
Carrying amounts
Balance	514,445	750,000
Developed Technology [Member]
Cost
Balance at Beginning	1,550,000
Additions		1,550,000
Impairments	(243,407)
Balance at Ending	1,306,593	1,550,000
Accumulated amortization
Balance at Beginning	301,389
Amortization	516,667	301,389
Balance at Ending	775,000	301,389
Carrying amounts
Balance	$ 531,593	$ 1,291,667

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - Schedule accounts payable and accrued liabilities - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Schedule Accounts Payable And Accrued Liabilities Abstract
Accounts payable (Note 12)	$ 138,276	$ 386,030
Due to related parties (Note 12 and Note 14)	304,623	302,883
Accrued liabilities (Note 12)	79,113	143,486
Total	$ 522,012	$ 832,399

Notes Payable _ Related Party_2

Notes Payable – Related Party (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 USD ($) shares	Dec. 31, 2021 CAD ($)
Disclosure Of Trade And Other Payables Text Block Abstract
Repaid of principal amount	$ 64,550		$ 462,228
Accrued interest (in Dollars)		$ 23,456		$ 38,301
Exchanged shares of common stock (in Shares) | shares			14,357
Principal reduction of debt			$ 1,483,738
Accrued interest			131,320
Loss on conversion			116,152
Finance expense		$ 60,770	$ 225,196

Notes Payable _ Related Party_3

Notes Payable – Related Party (Details) - Schedule of notes to their present value - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Notes To Their Present Value Abstract
Balance at Beginning	$ 2,786,183	$ 4,528,549
Proceeds
Repayments	(64,550)	(2,058,720)
Contribution benefit
Finance expense	60,770	225,196
Foreign exchange adjustment		91,158
Balance at Ending	2,604,713	$ 2,786,183
Current	2,604,713
Non-current	0
Foreign currency adjustment	$ (177,690)

Share Capital and Reserves (Det

Share Capital and Reserves (Details) - USD ($)	1 Months Ended			12 Months Ended
	Jan. 21, 2021	Nov. 17, 2020	Jul. 17, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 21, 2023
Share Capital and Reserves (Details) [Line Items]
Shares outstanding				338
Issued share capital description				i)Issued 291,667 units at a price of $24.00 per unit per unit for total proceeds of $7,000,000. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027. In connection with the offering, the Company incurred $900,720 in issuance costs as part of the transaction. ii)Issued 11,441 shares, which were converted from Versus Holdco shares.  iii)Issued 39,375 shares at a price of $22.20 per unit for total proceeds of $874,125 as a result of the underwriter exercising the overallotment.  iv)Issued 4,196 shares related to the Xcite acquisition and the vesting of key employee shares.  v)Issued 276,334 units at a price of $7.80 per unit for total proceeds of $2,155,195. The offering consisted of 140,000 common shares and 136,334 pre-funded warrants. In connection with the offering, the Company incurred $313,482 in issuance costs as part of the transaction.  vi)Issued 412,293 shares at $2.72 per share in a private placement offering for total proceeds of $1,119,373.     vii)Issued 2,100,000 units at a price of $1.00 per unit for total proceeds of $2,099,866. The offering consisted of 300,000 common shares and 1,800,000 pre-funded warrants. In connection with the offering, the Company incurred $522,460 in issuance costs as part of the transaction.	i)Issued 100,461 units at a price of $101.40 per unit in connection with the acquisition of Xcite. ii)Issued 98,134 units at a price of $112.50 per unit per unit for total proceeds of $11,040,000. Each unit consisted of one common share, one Unit A warrant and one Unit B warrant. Unit A warrants allow the purchaser to purchase one common share at $112.50 per share until January 20, 2026. Unit B warrants allow the purchaser to purchase one common share at $112.50 per share until January 20, 2026. In connection with the offering, the Company incurred $1,524,439 in issuance costs as part of the transaction.  iii)Issued 103,559 common shares pursuant to exercise of 95,689 warrants and 7,870 stock options for total proceeds of $6,735,254.  iv)Issued 14,357 units consisting of one share of common share and one Unit A warrant and one Unit B warrant in exchange for the forgiveness of $1,615,058 of debt and accrued interest.  v)Issued 1,954 shares of the Company’s common stock with a value of $206,614 to a third party in exchange for services (included in professional fees).  vi)Issued 2,916 shares related to the PPP loan escrow account that was included in the Xcite debt at the time of the acquisition.	i)Issued 10,000 units at a price of $45.30 per unit for total proceeds of $453,000. Each unit consisted of one common share and a one half share purchase warrant for each share purchased. Each whole warrant entitles the holder to purchase one additional common share at a price of $70.65 until February 17, 2021. ii)Issued 11,502 units at a price of $44.25 per unit for total proceeds of $508,969. Each unit consisted of one common share and one share purchase warrant for each share purchased.  iii)Issued 41,667 units at a price of $45.75 per unit for total proceeds of $1,906,250. Each unit consisted of one common share and a one half share purchase warrant for each share purchased.  iv)Entered into a Mutual Investment Agreement with Animoca Brands Inc. (Animoca) in which the Company issued 12,103 shares of the Company’s common stock with a value of $502,414 in exchange for 4,327,421 shares of Animoca common stock. On the same date, the Company issued an additional 5,939 shares of the Company’s common stock with a value of $251,169 to Animoca in exchange for services (included in professional fees). The Company subsequently sold all of its shares of Anomica and recognized a loss of $378,718.  v)Issued 70,660 common shares pursuant to exercise of 70,410 warrants and 250 stock options for total proceeds of $3,552,473.
Common shares issued and outstanding percentage				10%
Option vesting period				10 years
Share-based compensation (in Dollars)					$ 2,145,928	$ 1,049,135
Warrant balance (in Dollars)				$ 1,687,341
Share purchase warrants description				i)Completed a public offering on February 28, 2022, and issued 291,669 units at a price of $24.00 per unit per unit for total proceeds of $7,000,000. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027. ii)Issued 39,375 units on March 24, 2022, at a price of $22.20 per unit for total proceeds of $874,125 because the underwriter exercised its overallotment option. Each unit consisted of one common share and one warrant, to purchase one common share at $28.80 per share until February 28, 2027.  iii)Issued 414,500 warrants on July 18, 2022, to purchase common shares, each exercisable for one common share at an exercise price of $7.80 per share in an offer to an investor.  iv)Completed a public offering on December 9, 2022 and issued 2,100,000 units for total proceeds of $2,099,866. Each unit consists of (1) either (a) one common share or (b) one pre-funded warrant to purchase one common share and (2) two warrants to purchase one common share each, at a public offering price of $1.00 per unit. The unit will have an exercise price of $1.10 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. An additional 220,500 warrants were provided to placement agents with an exercise price of $1.25 per share.
Public offering issued	98,134
Public offering price per share (in Dollars per share)	$ 112.5
Total proceeds (in Dollars)	$ 11,040,000
Warrants issued	196,267
Warrants price per share (in Dollars per share)	$ 112.5
Common stock issued	14,357
Debt and accrued interest (in Dollars)	$ 1,615,058
Purchase of warrants		41,667	10,000
Warrants exercise price (in Dollars per share)		$ 73.35	$ 72.45
Term of warrants		2 years	2 years
Share purchase warrants fair value (in Dollars)
Private Placement [Member]
Share Capital and Reserves (Details) [Line Items]
Purchase of warrants			11,502
Warrants exercise price (in Dollars per share)			$ 70.65
Term of warrants			2 years
Share purchase warrants fair value (in Dollars)			$ 41,155
Stock Options [Member]
Share Capital and Reserves (Details) [Line Items]
Stocks option granted				104,520	64,015	31,339
Share-based compensation (in Dollars)				$ 1,567,583	$ 2,145,928
Class A Share [Member]
Share Capital and Reserves (Details) [Line Items]
Shares issued				338
Share purchase warrant [Member]
Share Capital and Reserves (Details) [Line Items]
Warrant balance (in Dollars)				$ 1,687,341
Warrants issued	14,357
A and B Warrants [Member] | Subsequent Event [Member]
Share Capital and Reserves (Details) [Line Items]
Warrants price per share (in Dollars per share)							$ 112.5
B Warrants [Member]
Share Capital and Reserves (Details) [Line Items]
Warrants issued	14,357

Share Capital and Reserves (D_2

Share Capital and Reserves (Details) - Schedule of outstanding stock options - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of outstanding stock options [Abstract]
Number of Outstanding, Balance	129,451	90,255
Weighted Average Excercise Price, Balance	$ 63.6	$ 55.5
Number of Outstanding, Balance	227,788	129,451
Weighted Average Excercise Price, Balance	$ 37.13	$ 63.6
Number of Outstanding, Granted	104,520	64,015
Weighted Average Excercise Price, Granted	$ 6.19	$ 73.05
Number of Outstanding, Exercised		(7,869)
Weighted Average Excercise Price, Exercised		$ 49.8
Number of Outstanding, Forfeited	(6,183)	(16,950)
Weighted Average Excercise Price, Forfeited	$ 92.81	$ 50.85

Share Capital and Reserves (D_3

Share Capital and Reserves (Details) - Schedule of fair value of stock options - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share Capital and Reserves (Details) - Schedule of fair value of stock options [Line Items]
Expected life of options	5 years	5 years
Expected dividend yield (in Dollars)
Bottom of Range [Member]
Share Capital and Reserves (Details) - Schedule of fair value of stock options [Line Items]
Risk-free interest rate	2.14%	0.04%
Volatility	96.90%	102%
Top of Range [Member]
Share Capital and Reserves (Details) - Schedule of fair value of stock options [Line Items]
Risk-free interest rate	4.03%	0.47%
Volatility	112.40%	128%

Share Capital and Reserves (D_4

Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	227,788
Options Exercisable	37.13
Exercise Price (in Dollars per share) | $ / shares	$ 3.82
June 6, 2023 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	937
Options Exercisable	85.5
Exercise Price (in Dollars per share) | $ / shares	$ 0.93
September 4, 2023 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	855
Options Exercisable	44.55
Exercise Price (in Dollars per share) | $ / shares	$ 1.18
April 2, 2024 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	7,129
Options Exercisable	37.8
Exercise Price (in Dollars per share) | $ / shares	$ 1.76
June 27, 2024 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	417
Options Exercisable	38.4
Exercise Price (in Dollars per share) | $ / shares	$ 1.99
September 27, 2024 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	20,005
Options Exercisable	67.95
Exercise Price (in Dollars per share) | $ / shares	$ 2.24
October 22, 2024 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	834
Options Exercisable	60.45
Exercise Price (in Dollars per share) | $ / shares	$ 2.31
July 31, 2025 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	16,139
Options Exercisable	44.7
Exercise Price (in Dollars per share) | $ / shares	$ 3.07
July 31, 2025 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	11,080
Options Exercisable	44.7
Exercise Price (in Dollars per share) | $ / shares	$ 3.07
August 10, 2025 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	833
Options Exercisable	44.7
Exercise Price (in Dollars per share) | $ / shares	$ 3.11
November 19, 2025 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	1,024
Options Exercisable	68.85
Exercise Price (in Dollars per share) | $ / shares	$ 2.39
June 1, 2026 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	3,788
Options Exercisable	105.6
Exercise Price (in Dollars per share) | $ / shares	$ 3.97
June 29, 2026 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	21,967
Options Exercisable	84.75
Exercise Price (in Dollars per share) | $ / shares	$ 3.97
August 19, 2026 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	38,260
Options Exercisable	63
Exercise Price (in Dollars per share) | $ / shares	$ 3.2
March 18, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	1,500
Options Exercisable	19.8
Exercise Price (in Dollars per share) | $ / shares	$ 4
May 10, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	800
Options Exercisable	11.85
Exercise Price (in Dollars per share) | $ / shares	$ 4
August 17, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	99,980
Options Exercisable	6
Exercise Price (in Dollars per share) | $ / shares	$ 4.8
September 20, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of incentive stock options outstanding [Line Items]
Options Outstanding	2,240
Options Exercisable	3.45
Exercise Price (in Dollars per share) | $ / shares	$ 4.8

Share Capital and Reserves (D_5

Share Capital and Reserves (Details) - Schedule of outstanding share purchase warrants - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of outstanding share purchase warrants [Abstract]
Number Outstanding, Balance	299,077	179,508
Weighted Average Exercise Price, Balance	$ 102.45	$ 54.15
Number Outstanding, Balance	5,278,535	299,077
Weighted Average Exercise Price, Balance	$ 5.74	$ 102.45
Number Outstanding, Exercised		(72,581)
Weighted Average Exercise Price, Exercised		$ 63.15
Number Outstanding, Expired	(186,586)	(32,830)
Weighted Average Exercise Price, Expired	$ 96.3	$ 63.15
Number Outstanding, Issued	5,166,044	224,979
Weighted Average Exercise Price, Issued	$ 3.42	$ 112.5

Share Capital and Reserves (D_6

Share Capital and Reserves (Details) - Schedule of assumptions in calculating the fair value of the warrants - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share Capital and Reserves (Details) - Schedule of assumptions in calculating the fair value of the warrants [Line Items]
Risk-free interest rate		0.25%
Expected life of warrants		1 year 9 months 3 days
Expected dividend yield (in Dollars)
Volatility		75%
Weighted average fair value per warrant (in Dollars per share)		$ 3.38
Bottom of range [member]
Share Capital and Reserves (Details) - Schedule of assumptions in calculating the fair value of the warrants [Line Items]
Risk-free interest rate	3.99%
Expected life of warrants	3 years 21 days
Expected dividend yield (in Dollars)
Volatility	119%
Weighted average fair value per warrant (in Dollars per share)	$ 0.26
Top of Range [Member]
Share Capital and Reserves (Details) - Schedule of assumptions in calculating the fair value of the warrants [Line Items]
Risk-free interest rate	4.22%
Expected life of warrants	5 years 18 days	8 months 12 days
Volatility	124.90%

Share Capital and Reserves (D_7

Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	5,278,535
Exercise Price | $ / shares	$ 5.74
Weighted Average Remaining Life	4 years 5 months 12 days
January 20, 2026 [Member]
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	112,491
Exercise Price | $ / shares	$ 112.5
Weighted Average Remaining Life	3 years 21 days
February 28, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	331,044
Exercise Price | $ / shares	$ 28.8
Weighted Average Remaining Life	4 years 1 month 28 days
December 6, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	220,500
Exercise Price | $ / shares	$ 1.25
Weighted Average Remaining Life	4 years 11 months 4 days
December 9, 2027 [Member]
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	4,200,000
Exercise Price | $ / shares	$ 1.1
Weighted Average Remaining Life	4 years 11 months 8 days
January 18, 2028 [Member]
Share Capital and Reserves (Details) - Schedule of share purchase warrants outstanding [Line Items]
Warrants Outstanding | shares	414,500
Exercise Price | $ / shares	$ 7.8
Weighted Average Remaining Life	5 years 18 days

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Transactions Between Related Parties Text Block Abstract
Occupancy costs	$ 64,741	$ 67,012
Accounts payable and accrued liabilities	304,623	302,883
Notes payable	$ 2,604,713	$ 2,786,183

Related Party Transactions (D_2

Related Party Transactions (Details) - Schedule of key management personnel - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of key management personnel [Abstract]
Key Management Personnel	$ 2,160,846	$ 1,954,722
CEO [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	350,657	335,430
CFO [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	363,291	447,710
Advisory Board [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	215,038	215,706
Chief Technology Officer [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	306,441	289,290
Director [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	293,585
Chief People Officer [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	205,681
Directors and Officers [Member]
Schedule of key management personnel [Abstract]
Key Management Personnel	$ 426,153	$ 666,586

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Disclosure Of Financial Risk Management Text Block Abstract
Exchange rate, percentage	10%
Net Loss	$ 15,200	$ 1,900

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Details) - Schedule of foreign currency risk - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Foreign Currency Risk Abstract
Cash	$ 245,858	$ 162,135
Accounts payable and accrued liabilities	(93,630)	(142,726)
Total	$ 152,228	$ 19,409

Geographical Segmented Inform_3

Geographical Segmented Information (Details) - Schedule of identifiable assets by geographic segments - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Geographical Segmented Information (Details) - Schedule of identifiable assets by geographic segments [Line Items]
Restricted deposits	$ 8,489	$ 9,068
Deposits	100,000	100,000
Goodwill	0	6,580,660
Property and equipment	172,841	326,945
Intangible assets	7,058,366	9,172,507
Canada [Member]
Geographical Segmented Information (Details) - Schedule of identifiable assets by geographic segments [Line Items]
Restricted deposits	8,489	9,068
Deposits
Goodwill
Property and equipment
Intangible assets
USA [Member]
Geographical Segmented Information (Details) - Schedule of identifiable assets by geographic segments [Line Items]
Restricted deposits
Deposits	100,000	100,000
Goodwill		6,580,660
Property and equipment	172,841	326,945
Intangible assets	$ 7,058,366	$ 9,172,507

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Non-cash investing and financing activities:
Contribution benefit on low interest rate notes			$ 170,329
Shares issued to acquire Holdco shares	11,441
Shares issued in connection with Xcite acquisition	4,196
Common shares issued to settle debt		107,671
Deferred financing costs included in accrued expenses		174,813	398,276
Fair value common shares issued in acquisition		$ 13,184,384

Lease Obligations and Commitm_3

Lease Obligations and Commitments (Details) - CAD ($)		1 Months Ended
	Sep. 06, 2017	May 31, 2018
Lease Obligations And Commitments Abstract
Monthly fee		$ 7,000
Agreement terms, description	Under the terms of the agreement the Company will pay $17,324 per month commencing on October 1, 2017 until June 30, 2023.

Lease Obligations and Commitm_4

Lease Obligations and Commitments (Details) - Schedule of lease liabilities - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Lease Liabilities Abstract
Lease liabilities recognized at beginning	$ 367,884	$ 641,251
Lease payments made	(260,184)	(251,383)
Interest expense on lease liabilities	20,860	39,836
Lease liabilities, Total	128,560
Less: current portion	(128,560)
At December 31, 2022 – non-current portion	$ 0	367,884
Foreign exchange adjustment		$ (61,820)

Lease Obligations and Commitm_5

Lease Obligations and Commitments (Details) - Schedule of rental agreement for office space	Dec. 31, 2022 USD ($)
Rental agreement [Member]
Lease Obligations and Commitments (Details) - Schedule of rental agreement for office space [Line Items]
2023	$ 131,576

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of income taxes at statutory rates - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of income taxes at statutory rates [Abstract]
Loss for the year	$ (21,762,333)	$ (17,847,892)	$ (6,911,040)
Expected income tax (recovery)	(5,876,000)	(4,819,000)	(1,866,000)
Change in statutory, foreign tax, foreign exchange rates and other	(12,000)	294,000	275,000
Permanent differences	1,875,000	1,107,000	403,000
Share issue costs	370,000	432,000
Adjustment to prior years provision versus statutory tax returns			(35,000)
Change in unrecognized deductible temporary differences	3,643,000	2,986,000	1,223,000
Income tax expense

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of deferred income taxes - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of deferred income taxes [Abstract]
Non-capital losses carry-forward	$ 14,519,000	$ 11,751,000	$ 7,841,000
Exploration and evaluation assets	1,470,000	1,470,000	1,470,000
Share issuance costs	789,000	735,000	109,000
Debt with accretion		(70,000)	(70,000)
Intangible assets	622,000	179,000	1,336,000
Other deferreds	12,000	37,000
Allowable capital losses	3,558,000	3,801,000	3,592,000
Property and equipment	76,000	35,000	64,000
Total	21,046,000	17,938,000	14,342,000
Unrecognized deferred tax assets	$ (21,046,000)	$ (17,938,000)	$ (14,342,000)

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of deferred income taxes unused tax credits and unused tax losses - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Non-capital losses available for future periods - US [Member[
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 41,188,000	$ 29,390,000
Expiry Date Range	2036 to indefinite	2036 to indefinite
Non-capital losses available for future periods - Canada [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 21,739,000	$ 20,664,000
Expiry Date Range	2026 to 2042	2026 to 2041
Allowable capital losses [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 13,178,000	$ 14,077,000
Expiry Date Range	No expiry date	No expiry date
Property and equipment [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 270,000	$ 128,000
Expiry Date Range	No expiry date	No expiry date
Intangible asset [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 2,962,000	$ 853,000
Expiry Date Range	No expiry date	No expiry date
Exploration and evaluation assets [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 5,446,000	$ 5,446,000
Expiry Date Range	No expiry date	No expiry date
Share issuance costs [Member]
Schedule of deferred income taxes unused tax credits and unused tax losses [Abstract]
Temporary Differences	$ 2,922,000	$ 2,724,000
Expiry Date Range	No expiry date	No expiry date

Subsequent Events (Details)

Subsequent Events (Details)		12 Months Ended
	Feb. 06, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2022 CAD ($) shares
Subsequent Events (Details) [Line Items]
Issuance of share units (in Shares) | shares		4,042,000	4,042,000
Exchange for the forgiveness		$ 1.1
Accrued interest		$ 4,446,200
Notes payable paid (in Dollars)			$ 50,000
Non-adjusting events after reporting period [Member]
Subsequent Events (Details) [Line Items]
Share issued (in Shares) | shares	2,500,000
Price per share (in Dollars per share) | $ / shares	$ 0.9
Other offering expenses payable	$ 2,250,000